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Abstract 
One purpose was to identify the need for specialized care (My Clinic) for women with a pre-
pregnancy body mass index (BMI) of ≥ 35 kg/m2. Women receiving My Clinic care were 
compared to a matched cohort control group (perinatal database, N=47). My Clinic care 
significantly reduced rates of macrosomia (5% vs 28%, p=0.02) and small birth weight 
babies (0% vs 6%, p=0.00) compared to perinatal database. 
The second purpose was to test the efficacy of a Nutrition and Exercise Lifestyle Intervention 
Program (NELIP) in this clinical setting to prevent excessive weight gain, macrosmia, small 
birth weight babies and pregnancy complications. Twelve women with a BMI ≥ 35 kg/m2 
were randomized between 12-20 weeks of pregnancy to Nutrition-only, Exercise-only, or full 
NELIP.  Exercise-only intervention reduced rate of weight gain (0.15 ± 0.13 kg/week vs 0.61 
± 0.12 kg/week, p=0.01) compared to Nutrition-only. Combining a nutrition and exercise 
intervention appeared difficult for this population, as 100% of the women randomized to full 
NELIP did not complete the program. 
Keywords 
“Obesity, gestational weight gain, exercise and pregnancy, nutrition and pregnancy, 
gestational diabetes mellitus, macrosomia, small birth weight” 
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Chapter 1  
1 Obesity  
The following chapter will begin by discussing the prevalence of obesity in the non-
pregnant individual. The chapter will review obesity management, psychosocial issues 
associated with obesity, physical activity and obesity, barriers and challenges of obesity 
and the role of health care practitioners in the treatment and prevention of obesity. The 
latter half of the chapter will focus on maternal obesity and discuss what has been learned 
from weight management issues in the non-pregnant obese population to assist in 
preventing excessive gestational weight gain in obese pregnant women. Increased 
pregnancy complications, childhood obesity risk and the risk of gestational diabetes 
mellitus as a result of obesity will also be discussed. Pregnancy weight gain guidelines 
will be examined, and physical activity during pregnancy will be discussed. Maternal 
obesity management and intervention strategies will be evaluated while considering the 
challenges and barriers to adopting a healthy lifestyle for an obese pregnant woman with 
a summary of factors that may relate to successful intervention strategies.  
1.1 Prevalence of Obesity 
Obesity is the second highest cause of preventable disability and death in the developed 
world (House of Commons Health Committee, 2004). Obesity is clinically defined by 
body mass index (BMI), which is calculated by dividing weight in kilograms by height in 
meters squared (kg/m2) (Gilmore, 1999). There are three classes of obesity outlined by 
the World Health Organization (WHO, 1997). A BMI of 30.0 to 34.9kg/m2 constitutes 
Obese Class I (high risk of developing health problems), 35.0 to 39.9kg/m2 constitutes 
Class II (very high risk), and ≥40.0kg/m2 constitutes Class III (extremely high risk) (see 
Table 1). The WHO estimates that 1.9 million people die annually as a result of physical 
inactivity, while 2.6 million people die as a direct result of being overweight and/or obese 
(Tunstall-Pedoe, 2006). The morbidity and mortality associated with obesity presents a 
huge economic burden on the Canadian health care system (Plourde, 2006). Over a 
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decade ago, in 2001, the cost of obesity was estimated at $4.3 billion per year (Pirkola et 
al., 2010).  
Table 1: Body mass index (BMI) classification related to health risks for men and 
women 
 BMI range Risk of developing health 
problems 
Underweight <18.5 Increased 
Normal weight 18.5 to 24.9 Least 
Overweight 25.0 to 29.9 Increased 
Obese Class I 30.0 to 34.9 High 
Obese Class II 35.0 to 39.9 Very high 
Obese Class III ≥40.0 Extremely high 
Source: Davies et al., 2010 
1.1.1 Obesity Management 
The Canadian Obesity Network (2011) describes obesity as a chronic and often 
progressive condition that requires realistic and sustainable treatment strategies for 
successful weight and health management (Canadian Obesity Network, 2011). To best 
treat obesity the ‘5 A’s of Obesity Management’ were created for the non-pregnant 
population. Firstly, health care providers must ask for permission to discuss weight, as it 
is a sensitive issue that may evoke feelings of embarrassment, fear, blame and stigma. 
Secondly, all obesity related risks based on BMI classification and potential causes of 
weight gain should be assessed. Thirdly, health care providers should advise on obesity 
risks and discuss the benefits of weight loss and treatment plans. Emphasis should be 
placed on improving overall health and well-being rather than weight loss. Health care 
providers and patients should agree on realistic weight-loss expectations and initiate a 
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SMART plan (specific, measurable, achievable, rewarding and timely goals). It is 
important to help patients set weight targets based on a weight that is sustainable while 
still enjoying life. Unrealistic weight-loss expectations can lead to disappointment and 
non-adherence. Lastly, providers should assist in addressing barriers, and offer education, 
resources, referrals and follow-up appointments as necessary. It is important to identify 
the ‘root causes’ of weight gain when considering the barriers to weight management. 
Weight gain may result from a reduction in metabolic rate, overeating, or reduced 
physical activity. However, these factors typically stem from psychological or 
socioeconomic issues (Canadian Obesity Network, 2011).  
1.1.2 Psychosocial Issues of Obesity 
Stress during childhood has been associated with increased risk for weight problems 
during adolescence and adulthood (Johnson et al., 2002). Eating disorders, anxiety and 
compulsive behaviours seen in adult obese patients are often associated with past or 
ongoing abuse (whether that be physical, sexual or emotional) (Grilo et al., 2006). Van 
der Waerden et al. (2013) found that exercise has both a preventative and therapeutic 
impact on mental health problems that occasionally underlie an obesity diagnosis. The 
study attempted to reduce stress and depressive symptoms in women with low-
socioeconomic status using a group-based program consisting of part physical exercise 
and part psycho-education (Van der Waerden et al., 2013). The psycho-education 
component involved a multi-component intervention developed to counter the negative 
effects of stressful events, reduce depressive symptoms and improve access to 
psychological resources (Van der Waerden et al., 2013). The intervention was non-
stigmatizing, as it was presented and executed as a course rather than therapy. This was 
important in low SES groups as they are more likely to report stigma concerns for mental 
health issues, which may inhibit their use of mental health services (Grote et al., 2007). 
Literature typically suggests that a population of women with low-socioeconomic status 
is generally considered hard to reach for participation in prevention and research trials 
(Gadalla, 2008). However, it was found that exercise alone or in combination with 
psycho-education is a viable prevention option for disadvantaged women, especially 
those women with low-socioeconomic status who have been found to have higher rates of 
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stress, depression and anxiety (Van der Waerden et al., 2013). It is recommended that 
health care professionals complete mental health screening, as deemed appropriate on 
obese adults (Lau et al., 2006).  
Obesity prevalence is greater in lower socioeconomic groups (Mauro et al., 2008). This 
can be attributable to the greater number of fast-food restaurants in low-income 
neighbourhoods, the high cost of healthy food, safety concerns that prevent walking or 
outdoor activities, and greater social acceptance of excess body weight (Mauro et al., 
2008). The affordability of gym memberships, commercial weight-loss programs and 
obesity medications may also be barriers for low-income individuals (Mauro et al., 2008).  
1.1.3 Physical Activity and Obesity 
Sedentary lifestyle contributes to the prevalence of overweight and obesity (Ball et al., 
2000; National Audit Office, 2001). Increased exercise engagement should therefore be 
one tool to tackle the ‘obesity epidemic’ (Tunstall-Pedoe, 2006). Simple activities like 
walking, rather than vigorous exercise or competitive sports, is one strategy that should 
be targeted to obese individuals (Ball et al., 2000). The use of a pedometer as a tracking 
device and feedback tool is an effective way to increase physical activity (Tudor-Locke et 
al., 2002). Taking 10,000 steps per day is considered an active lifestyle; 3100-4000 steps 
taken are equivalent to 30 minutes of walking at a moderate intensity (Tudor-Locke et al., 
2002). Promotion of regular physical activity will potentially deliver multiple health 
benefits at a population level through reducing the health effects associated with 
inactivity, overweight and obesity (Ball et al., 2000).  
1.1.4 Barriers to Physical Activity in Obese Individuals 
Little research has been conducted on exercise initiation and maintenance among obese 
individuals (Biddle & Fox, 1998). A significant proportion (22.6%) of obese participants 
report that being too fat is a barrier to increasing their level of physical activity, and many 
of these respondents were women (Ball et al., 2000). Other intrapersonal barriers reported 
include comorbidities (mental health, sleep, pain, cardiovascular (CV) disease, etc.), an 
injury or disability, too shy or embarrassed, not athletic, being generally unmotivated and 
lazy to initiate an exercise program, disproportionate focus on weight loss, and previous 
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negative experiences with exercise (Ball et al., 2000; Chambliss et al., 2004; Mauro et al., 
2008). Environmental factors such as proximity to facilities, as well as personal factors 
such as time constraints and children, are common barriers frequently reported by both 
normal and overweight individuals (Chambliss et al., 2004). Further research is required 
to consider the intrapersonal factors that reinforce the initiation and maintenance of 
physical activity among the obese (Ball et al., 2000).                 
1.1.5 Challenges and Barriers of Obesity 
One of the most successful and recent prevention interventions in public health was 
promoting smoking cessation (Volkow & Wise, 2005). The obesity epidemic offers a 
unique challenge, as food, unlike cigarettes, is necessary for survival. It is difficult for a 
society to implement regulations that will limit easy access to food that can lead to 
compulsive eating. Restricted access to high-fat high-calorie foods that are unnecessary 
for the maintenance of good health is required, particularly in public places (Volkow & 
Wise, 2005).  
It is essential that health behaviour counseling is framed in a positive manner (emphasize 
the health benefits of increased physical activity and weight loss) rather than in a negative 
manner (emphasizing the detrimental effects of remaining obese) (Forman-Hoffman et 
al., 2006). Some clinicians believe that having obese patients complete questionnaires 
rating their readiness to change prior to the visit would be helpful (Forman-Hoffman et 
al., 2006). Further research is required to determine the effectiveness of this strategy.  
Whether health care providers accept obesity as a chronic disease influences the way 
obese patients are counseled; 83% of clinicians who considered obesity a disease 
counseled their patients in a positive context, while only 50% of clinicians who did not 
consider obesity a disease counseled their patients in a positive context (Forman-
Hoffman et al., 2006). Clinicians who believe obesity is a disease may be more 
compassionate towards obese patients versus those clinicians who believe obesity is a 
result of a character flaw or a lack of willpower (Forman-Hoffman et al., 2006). Research 
indicates that health care providers who are most likely to counsel patients on weight 
management practices initiated conversations by “medicalizing” the obesity (Kizer et al., 
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2000). In a recent report, the American Heart Association (AHA) now considers obesity a 
disease (Jensen et al., 2013) and advocates weight loss in obese individuals to prevent 
heart disease and stroke, America’s number one and number four killers, respectively 
(Jensen et al., 2013). The health problems and risk factors of obesity that are being passed 
down through the generations can no longer be ignored (Jensen et al., 2013). A 
collaborative effort between the AHA, the American College of Cardiology (ACC) and 
the National Heart, Lung, and Blood Institute (NHLBI) resulted in updated evidence-
based guidelines designed for health care providers to help patients lose weight and keep 
it off (Jensen et al., 2013). 
1.1.6 Obesity and Health Care Practitioners 
Participation of the medical community will be required to initiate large-scale prevention 
and treatment programs for obesity (Volkow & Wise, 2005). There are various provider 
level barriers that influence the management of obesity in primary care. Primary care 
practitioners may have a perceived inability to change patient behaviours, negative 
attitudes toward obese patients, a belief that patients are not interested or ready for 
treatment, or a belief that obesity is the responsibility of the patient (Forman-Hoffman et 
al., 2006). Furthermore, practitioners commonly have a lack of formal training in 
nutrition, obesity and weight management counseling (Forman-Hoffman et al., 2006). 
Few clinicians (23.6%) report learning beneficial obesity management practices in 
medical school and residency training programs (Forman-Hoffman et al., 2006). Weight 
management education would be beneficial to make obesity a higher priority for health 
care providers (Forman-Hoffman et al., 2006). The engagement of obstetricians, 
pediatricians and family physicians will aid in the prevention of obesity for the next 
generation (Volkow & Wise, 2005). More formal training for physicians, nurses, 
psychologists and social workers is required for improved management and prevention of 
obesity (Volkow & Wise, 2005). 
It is unknown whether health behaviour and dietary counseling led by practitioners 
actually motivates patient behaviour (Forman-Hoffman et al., 2006). Patients and 
clinicians alike express the need for increased ease of access to obesity educators, 
dieticians, physical therapists and behavioural counselors for a well-rounded approach to 
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health and weight management (Forman-Hoffman et al., 2006). Research demonstrates 
that many primary care clinicians do not regularly counsel or refer obese patients to 
weight management services (Forman-Hoffman et al., 2006). In one study, personal 
dietary vigilance by clinicians impacted the likelihood of regularly calculating the BMI of 
obese patients, with more vigilant clinicians being more likely to calculate BMI (Forman-
Hoffman et al., 2006). There is conflicting literature as to the effect of weight 
management counseling initiated by clinicians who have a personal history of obesity. 
One study found that these clinicians were more likely to provide obesity counseling to 
patients (Epstin & Ogden, 2005). On the contrary, another study concluded that patients 
were more receptive to health counseling provided by non-obese physicians (Epstin & 
Ogden, 2005). 
More often than not, primary care practitioners are not properly trained in the 
management of obesity. A well-rounded team of formally trained physicians, nurses, 
psychologists, social workers and kinesiologists is ideal to initiate and manage obesity 
treatment and prevention programs.  
1.2 Maternal Obesity in Pregnancy 
There has been a significant rise in the incidence of obesity among pregnant women, 
consistent with the increasing number of obese individuals (Hillier et al., 2007; 
Hiramatsu et al., 2000; Katzmarzyk et al., 2008); about 50% of women of childbearing 
age (20 to 34 years) are overweight or obese (Nascimento et al., 2012). In Canada alone, 
the number of overweight and obese women of childbearing age has increased by 80,409 
in a four-year span from 2008 to 2012 (Statistics Canada, CANSIM, 2013). 
Consequently, the occurrence of pediatric obesity (among infants 0-11 months) in Canada 
is increasing at a frightening rate (Plourde, 2006). An overweight or obese child has a 
predisposition towards obesity as an adult (Shankar et al., 2008; Vanasse et al., 2006), 
which is bound to have critical consequences on Canadian health care as a generation of 
these obese children mature. Healthy lifestyle interventions targeting school-aged 
children occur too late to prevent childhood obesity (Wardle et al., 2006). Clinical 
research, therefore, suggests that prevention of obesity be initiated as early as pregnancy 
(Plourde, 2006). The Institute of Medicine (IOM) has outlined a specific range of 
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recommended gestational weight gain for obese women, based on pre-pregnancy BMI, 
with both the welfare of the infant and health of the mother being priority (Institute of 
Medicine, 2009). The antenatal period provides an opportunity to manage weight to 
reduce both maternal and fetal complications associated with excessive weight gain and 
maternal obesity (Nascimento et al., 2012).  
Maternal obesity in pregnancy can lead to a lifetime of unhealthy weight for mother and 
baby (Mottola et al., 2010). Excessive weight gain during pregnancy is often followed by 
maternal weight retention postpartum, and these are independent predictors of long-term 
weight gain and obesity (Phelan et al., 2011). The cycle of excessive gestational weight 
gain and postpartum weight retention continues with each pregnancy thereafter, causing 
BMI to increase with each new child born, thus increasing the health risks associated 
with obesity. Pregnancy presents a time of powerful emotional, social, identity and 
physical changes, as well as a new awareness that maternal behaviour may impact 
offspring health (Phelan et al., 2014). This new awareness during pregnancy may provide 
an incentive for women to adopt healthy nutrition and physical activity behaviours 
(Phelan et al., 2014). Aggressive preventative management is recommended for all 
overweight and obese women prior to pregnancy, during pregnancy and after delivery to 
reduce the risk of pregnancy complications and health issues for both mother and baby in 
the future (American College of Obstetricians & Gynecologists, 2005). The increasing 
prevalence of maternal obesity demands an even more rigorous intervention strategy 
carried out by a team of health care practitioners to properly manage treatment in an 
obese pregnant woman. 
1.2.1 Maternal Obesity Increases Pregnancy Complications 
There are numerous medical complications associated with maternal obesity that may 
arise during pregnancy. Depending on pre-pregnancy BMI, an increased risk of 
macrosomia (birth weight >4.0 kg), augmentation of labour, gestational hypertension and 
neonatal metabolic abnormalities can occur (Davies et al., 2010). With maternal obesity 
there is an increased rate of fetal anomalies, one being neural tube defects (Davies et al., 
2010). One study reported a two-fold increase in neural tube defects in the offspring of 
obese women (Nuthalapaty & Rouse, 2004). A dose response was also noted, with 
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heavier women having an even higher risk (Nuthalapaty & Rouse, 2004). Repeat 
ultrasounds may be required for women with a BMI above the 90th percentile and 
obstetricians should consider BMI when scheduling a fetal anatomic assessment in the 2nd 
trimester (Davies et al., 2010; Wolfe et al. 1990). Earlier ultrasounds may be optimal for 
high-risk, high BMI pregnancies to detect abnormalities sooner rather than later. 
Further pregnancy complications include spontaneous abortion, more severe forms of 
preeclampsia, and gestational diabetes mellitus (GDM). The obese population is at an 
increased risk of recurrent early miscarriages (Lashen et al. 2004). The most prevalent 
risk factor for unexplained still birth is pre-pregnancy obesity (Fretts, 2005). Fetal and 
uterine monitoring are challenging intrapartum complications, due to the maternal pannus 
and difficulty transducing fetal heart rate and maternal contractions (Davies et al., 2010). 
Maternal obesity is associated with an increased rate of Caesarean sections due to 
macrosomia and the possibility of shoulder dystocia (Davies et al., 2010). Caesarean 
section rates were 14.3% for lean women (BMI<19.8kg/m2) and 42.6% for very obese 
women (BMI≥35.kg/m2) (Perlow & Morgan, 1994; Wall et al., 2003). Furthermore, 
obese women undergoing Caesarean section experience more complications, which may 
include blood loss >1000mL, increased operative time, increased postoperative wound 
infection and endometritis, and the need for vertical skin incision (Perlow & Morgan, 
1994; Wall et al., 2003). Obstetric anesthesia complications and the risk of epidural 
failure are increased in obese women (Davies et al., 2010). Multiple attempts at catheter 
placement for anesthesia may also be required (Davies et al., 2010).  
1.2.2 Maternal Obesity Increases Childhood Obesity Risk 
Maternal obesity in early pregnancy may increase the risk of offspring obesity in 
childhood, adolescence, and adulthood (Laitenen et al., 2012). Maternal weight gain >7.0 
kg during the first half of pregnancy is associated with a nearly 1.5-fold increased risk for 
a child to be overweight or obese in adolescence (Laitenen et al., 2012). Statistics 
indicate that children of obese mothers are twice as likely to be large for gestational age 
at birth, and are more likely to be obese at preschool age (Hiramatsu et al. 2000; Mottola 
et al., 2010). Moreover, research suggests that early exposure to certain diets during fetal 
life can influence the food preferences of an individual later in life (Mennella et al. 2004; 
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Volkow & Wise, 2005). Childhood obesity has repeatedly shown to be a strong predictor 
of adult obesity (Flynn et al., 2006; Plourde, 2006), particularly in those children who are 
overweight and experience adolescent obesity or have at least one parent who is obese 
(Flynn et al., 2006).  
There is growing research demonstrating the in utero environment is a predictor of future 
neonatal, child and adult health risks (Simmons, 2008). Data consistently suggest that 
excessive maternal weight gain and pre-pregnancy BMI have been correlated with birth 
weight (Mottola, et al., 2010). Overweight and/or obese women are at an increased risk of 
giving birth to larger babies (>90th percentile), even after controlling for GDM (Nomura 
et al., 2012; Shankar et al., 2008). The odds of an infant weighing more than 4.0kg at 
birth was 1.7 times greater for obese mothers and 2.0 times greater for obese mothers of 
Class 2/3 (Bellver et al., 2003). Maternal obesity has been shown to be an independent 
risk factor for macrosomic infants (Artenisio, et al., 1999). Excessive gestational weight 
gain may also predict macrosomia as the majority of Canadian women (58%) who gained 
more weight than recommended gave birth to an infant weighing 4.0 kg or more (Lowell 
& Miller, 2010). Furthermore, a 1kg increment in birth weight in full-term infants was 
associated with an approximate increase of 50% in the risk of the child being overweight 
at ages 9-14 years (Gillman et al., 2003).  
1.2.3 Maternal Obesity and Gestational Diabetes Mellitus (GDM) 
Risk 
Excessive maternal weight gain is associated with a substantially higher risk of GDM 
(Chu et al., 2007), as an elevated BMI is a major risk factor for developing GDM 
(Davenport et al., 2010). A positive relationship exists between BMI and maternal 
glucose disorders. Davenport et al. (2010) noted that as pre-pregnancy BMI increased, 
the prevalence of maternal glucose disorders also increased. GDM diagnosis during 
pregnancy has been associated with increased Caesarean section deliveries due to the 
incidence of large for gestational age (LGA) babies, as well as gestational hypertension 
(Davenport et al., 2010). GDM affects 3-4% of Canadian pregnancies and this statistic is 
on the rise due to the obesity epidemic and decreasing physical activity (Canadian 
Diabetes Association, 2003; Catalano et al., 2009; Dempsey et al., 2004; Dempsey et al., 
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2004A; Ferrara, 2007; Jovanovic & Pettitt, 2001). In London, Canada, the prevalence of 
GDM has increased by 52%, while the incidence of type 2 diabetes has increased by 
206% between 2000 and 2009 (Davenport et al., 2010).  
The diagnostic criteria for GDM remain controversial and the 2013 CDA guidelines 
differ from those of the American Diabetes Association (ADA, 2013; CDA, 2013). The 
2013 CDA expert committee chose a preferred approach and an alternate approach to 
screening GDM. The preferred approach begins with a 50 mg glucose challenge test, and 
if appropriate, is followed up with a fasted 75 g oral glucose tolerance test (OGTT). 
GDM is diagnosed with ≥1 abnormal value. The increased maternal and perinatal 
morbidity associated with GDM resulted in both the CDA and ADA guidelines outlining 
GDM screening as standard of care for all women, despite risk factors (CDA, 2013). 
There is escalating evidence of long-term complications, such as obesity and diabetes, in 
children of women with maternal obesity and GDM (Hiramatsu et al., 2000). These long-
term complications can include an increased risk of developing obesity, impaired glucose 
tolerance, type 2 diabetes and chronic disease (Dunger et al., 2007; Hillier et al., 2007). 
Emerging evidence suggests that maternal pre-pregnancy BMI is one of several key 
factors that influence childhood weight gain and adiposity (Baker et al., 2004; Catalano et 
al., 2009; Whitaker, 2004). Maternal pre-pregnancy BMI is significantly associated with 
abnormal fetal growth, and further, childhood overweight and obesity (Catalano et al., 
2009). While maternal obesity is commonly linked to macrosomic infants, obese women 
with a BMI >30 kg/m2 are also at risk for having a pregnancy complicated by a small 
birth weight infant (Leddy et al., 2008). The “catch-up growth” phenomenon links small 
birth weight infants to early onset obesity and the subsequent emergence of metabolic 
syndrome with increasing age. Stroeschu et al. (2014) found an increased prevalence of 
metabolic syndrome in those born small compared to appropriate for gestational age 
growth starting at puberty.  
In a cohort of low income children, maternal obesity during pregnancy more than 
doubled the risk of obesity in children (Whitaker, 2004). Hyperglycemia during 
pregnancy, a consequence of GDM, is correlated with obesity in children aged 5-7 years 
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(Hillier et al., 2007), while childhood obesity is associated with a dramatic increase in the 
prevalence of chronic disease (Flynn et al., 2006). Risk factors for chronic cardiovascular 
disease, specifically hypertension, as well as impaired glucose tolerance, dyslipidemia 
and hyperinsulemia have all been identified in obese children as young as 5 years (Csabi 
et al., 2000; Flynn et al., 2006). The combination of obesity and chronic disease are 
undeniably early risk factors for future morbidity in adulthood (Plourde, 2006). Maternal 
nutrition and physical activity are incredibly important during pregnancy as they impact 
the offspring risk of developing obesity and metabolic disease (Catalano et al., 2009). 
Physical activity during pregnancy in particular has been shown to significantly reduce 
the risk of GDM (Davies et al., 2010).  
1.2.4 Physical Activity During Pregnancy in Non-Obese Women 
Pregnant women seek medical care more readily and are often highly motivated to make 
healthy lifestyle changes (Artal et al., 2007). Not only does a lifestyle intervention 
program using nutrition and exercise reduce pregnancy weight gain, it also improves 
pregnancy outcomes and can have a significant impact on future behaviours (Artal et al., 
2007). Pregnancy, therefore, provides an ideal time to make lasting lifestyle changes 
(Artal et al., 2007).  Unfortunately, pregnancy has also been associated with a sharp 
decline in exercise and an increase in sedentary behaviour (Gaston and Cramp, 2011). 
Few pregnant women are meeting exercise guidelines due to a decrease in frequency and 
intensity from pre-pregnancy to pregnancy (Gaston and Cramp, 2011). For pregnancy 
specifically, a commonly cited barrier is fatigue (Gaston and Cramp, 2011).  
A growing body of literature suggests women be encouraged to participate regularly in 
physical activity during pregnancy (Davies et al., 2003). Physical activity during 
pregnancy has numerous benefits in addition to the prevention of excessive weight gain, 
some of which include improved psychological well-being (Hartmann & Bung, 1999), 
improved response to a carbohydrate load (Jovanovic-Peterson & Peterson, 1996), 
decreased incidence of macrosomic babies resulting in delivery complications (Pivarnik, 
1998) and quicker recovery following delivery (Giroux et al., 2006). Exercise during 
pregnancy is associated with higher cardiorespiratory fitness, prevention of low back 
pain, decreased symptoms of depression, and decreased insulin use for those with GDM 
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(Nascimento et al., 2012). The literature consistently indicates that physically active 
pregnant women feel better and experience fewer symptoms (including shortness of 
breath, backaches, headaches, vomiting and hot flashes) associated with pregnancy 
(Gaston and Cramp, 2011).  
1.2.5 Assessing Physical Activity Readiness During Pregnancy  
The Canadian Society for Exercise Physiology has developed a Physical Activity 
Readiness Medical Examination for Pregnancy (PARmed-X) tool as a guideline for 
health screening prior to participation in prenatal exercise. PARmed-X for pregnancy is a 
convenient checklist for health care providers to evaluate patients and can be used for 
ongoing medical surveillance during pregnancy (PARmed-X for Pregnancy, CSEP, 
2013). PARmed-X for pregnancy prescribes a prenatal fitness program based on the FITT 
principle (frequency, intensity, time and type of exercise). In terms of aerobic exercise, it 
is recommended that pregnant women exercise three to four times weekly at a moderate 
intensity (Davies et al., 2003; PARmed-X for Pregnancy, CSEP, 2013). Intensity of 
exercise should be monitored using a combination of a target heart rate range and a rating 
of perceived exertion (RPE) scale. Lower target heart rate zones are recommended for 
pregnant women with a pre-pregnancy BMI of >25kg/m2 with a target range of 102-124 
beats per minute (bpm) for a maternal age of 20-29 years, and 101-120 bpm for a 
maternal age of 30-39 years (Davenport et al., 2008). Pregnant women should attempt to 
exercise for 15 minutes, even if it means reducing the intensity. Rest intervals may be 
incorporated. Non-weight bearing or low-impact endurance exercises using large muscle 
groups (e.g., walking, stationary cycling, swimming, aquatic exercises, low impact 
aerobics) is recommended, preceded by a brief warm up and followed by a short cool 
down (PARmed-X for Pregnancy, CSEP, 2013).  
1.2.6 Pregnancy Weight Gain Guidelines 
To improve maternal and child health outcomes, women should aim to remain within the 
projected pregnancy weight gain recommendations. The Institute of Medicine (2009) has 
issued pregnancy weight gain guidelines based on BMI (see Table 2). Underweight 
women (<18.5 kg/m2) are recommended to gain 12.7-18.1 kg during pregnancy at a rate 
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of 0.45 kg/week. Normal weight women (18.5-24.9 kg/m2) are recommended to gain 
11.3-15.9 kg at a rate of 0.45 kg/week. Overweight women (25.0-29.9 kg/m2) are 
recommended to gain 6.8-11.3 kg at a rate of 0.32 kg/week. Lastly, obese women (≥30.0 
kg/m2) are recommended to gain 5.0-9.0 kg at a rate of 0.27 kg/week (Institute of 
Medicine, 2009). These calculations assume a 0.5-2.0 kg weight gain in the first trimester 
(Institute of Medicine, 2009). A range of weight gain is necessary because a single 
number cannot accommodate factors such as age and race/ethnicity that may affect 
pregnancy outcomes.  
Table 2: Recommendations for total and rate of weight gain during pregnancy by 
pre-pregnancy body mass index (BMI) 
Pre-pregnancy BMI  BMI Total weight gain 
range (kg)  
Rates of weight gain 
2nd and 3rd trimester 
(maximum kg rate 
per week) 
Underweight <18.5 12.7-18.1 0.45 
Normal weight 18.5-24.9 11.3-15.9 0.45 
Overweight 25.0-29.9 6.8-11.3 0.32 
Obese (includes all 
classes) 
≥30.0 5.0-9.0 0.27 
Source: IOM, 2009 
Those who are obese at the time of conception are recommended to gain less pregnancy 
weight in total compared to a woman of normal weight (Institute of Medicine, 2009). A 
substantial number of pregnant women surpass these goals (Polley et al., 2002). In a 
study of over 4000 women from the University of California, 70% of overweight (BMI 
≥25 kg/m2) women exceeded the recommendations (Polley et al., 2002). In another study, 
42% of women gained excessively according to the Institute of Medicine recommended 
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guidelines (Olson et al., 2003). Lastly, Pereira et al. (2007) found that 52.7% of women 
in all BMI categories had excessive gestational weight gain. Canadian statistics reveal 
similar findings. Women with a higher pre-pregnancy BMI were more likely than normal 
or underweight women to gain more weight than recommended during pregnancy 
(Lowell & Miller, 2010). Fifty-five % of overweight/obese pregnant women gained more 
than the IOM gestational weight gain guidelines, compared with 41% of those who were 
normal weight and 25% who were underweight (Lowell & Miller, 2010).  
Few pregnant women report being counseled correctly regarding weight gain and the 
risks associated with excessive gestational weight gain by their health care practitioner 
despite the revised 2009 IOM guidelines. Only 28.5% of the women reported their health 
care provider made a recommendation about how much weight they should gain, while 
25% reported being told the risks of inappropriate or excessive weight gain (McDonald et 
al., 2011). A mere 12% of the women achieved the recommended weight gain in 
accordance with the 2009 IOM guidelines (McDonald et al., 2011). 
A significant number of patients (51.3%) reported that gestational weight gain was not 
discussed at all during their first prenatal appointment, while 44.8% of patients reported 
that exercise during pregnancy was not discussed (McDonald et al., 2011). Evidently, 
there is a need for better patient education to improve the knowledge deficit for many 
pregnant women regarding the recommended weight gain guidelines (McDonald et al., 
2011). Tovar et al. (2010) found similar results while evaluating the knowledge about 
gestational weight gain in Hispanic women; a group typically found to have higher 
obesity rates. The majority of the overweight and obese women reported that they had not 
received any recommendations from physicians for weight gain during their pregnancy 
(Tovar et al., 2010). For those who received gestational weight gain education, pregnancy 
weight gain advice was not always consistent with IOM guidelines and was found to vary 
widely (Tovar et al., 2010).  
1.2.7 New Literature in Pregnancy Weight Gain Guidelines 
New research has just recently suggested that IOM weight gain guidelines are just that – 
recommendations that reserve the right to be individualized on a case by case basis, 
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taking into account known risk factors. This matter is complicated by the American 
Congress of Obstetrics and Gynecology committee, who recently suggested there may be 
potential benefits of gaining below guidelines for an obese woman, as long as the fetus is 
growing at a healthy rate (Kapadia et al., 2015). However, accurate clinical estimation of 
fetal growth using ultrasound is especially difficult in obese women and may not always 
be reliable.  
Kapadia et al. (2015) aimed to determine the risk of adverse pregnancy outcomes with 
GWG below 2009 IOM guidelines and within the guidelines in obese women. Primary 
outcome measurements were preterm birth, small for gestational age (SGA) and large for 
gestational age (LGA). SGA was defined as birth weight less than 3rd and less than 5th 
percentile for sex and gestational age, while LGA was defined as birth weight >95th and 
>97th percentile for sex and gestational age. GWG below the guidelines had higher odds 
of preterm birth and SGA babies and lower odds of LGA than GWG within the 
guidelines.  
Swank et al. (2014) conducted a retrospective cohort study where super obese women 
(BMI ≥50 kg/m2) were stratified to below, within and above IOM GWG guidelines. 
Weight gain below IOM guidelines was not associated with statistically significant 
increased odds of preterm birth or small babies, while LGA was significantly reduced for 
the super obese women. Excessive weight gain statistically increased odds of pregnancy 
induced hypertension and Cesearean delivery, while not reducing odds of small birth 
weight babies. Swank et al. (2014) suggested that minimal weight gain in this population 
is not detrimental to fetal growth, and may actually be protective against the development 
of macrosomia. In summary, the study found that women with BMI ≥50 kg/m2 may 
warrant individualized GWG recommendations. 
As previously mentioned, it is recommended that obese women gain 5-9 kg during 
pregnancy. It is interesting to note that gaining the lower limit of this range would 
actually result in maternal weight loss following birth, since approximately 6 kg of 
weight gained during pregnancy can be attributed to additional extracellular fluids, blood, 
amniotic fluid, growth of the uterus and breast tissue, and the placenta (Kapadia et al., 
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2015). It is difficult to recommend GWG below the 2009 IOM guidelines considering the 
lack of research as of late, as well as the increased risk of small birth weight and preterm 
birth. GWG should be monitored closely, taking into account IOM recommendations and 
individual risk factors.  
1.2.8 Excessive Gestational Weight Gain and Weight Retention 
For many women, obesity is initiated by an excessive weight gain during pregnancy 
(Clark and Odgen, 1999). Numerous studies have found that pre-pregnancy weight is a 
strong predictor of 12-month post-partum weight retention (Hartmann & Bung, 1999; 
Moher et al., 2012). Overweight and obese women retain more weight post-partum 
versus normal weight women (Harmann & Bung, 1999; Moher et al., 2012). A higher 
pre-pregnancy weight is also associated with exceeding weight gain goals in accordance 
with IOM recommendations (Nohr et al., 2008).  
Women in the normal, overweight and obese BMI categories who gained excessively 
during pregnancy retained significantly more weight at one year post-partum (Olson et 
al., 2003). Statistics Canada reports that women who gained more weight than 
recommended during their pregnancy retained more weight (4.5 kg on average) than 
women who gained within (2.0 kg) or below the 2009 IOM recommendations (0.5 kg) 
(Lowell & Miller, 2010). Clark and Odgen (1999) reported that women who later went on 
to develop morbid obesity following pregnancy had already gained 4 kg more than the 
control women at a mere 6 weeks post-partum. Overweight and obese women may 
require more intensive lifestyle interventions to reduce excessive gestational weight gain 
and weight retention than normal weight women (Phelan et al., 2014). This is particularly 
true for obese women because of the more restricted recommended range of weight gain 
(Phelan et al., 2014).  
1.2.9 Maternal Obesity Management 
All pregnant women, including those who are obese, are advised to keep gestational 
weight gain within the IOM recommended parameters (classified by pre-pregnancy  
BMI) to improve the health and well-being of both mother and baby. The Canadian 
Obesity Network recently released a guide for practitioners titled the “5 A’s of Healthy 
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Pregnancy Weight Gain,” addressing how to manage obese pregnant women in 
particular. After weight gain recommendations have been established early in pregnancy, 
it is important to identify and discuss the “root causes” of obesity itself, as well as the 
myths and barriers associated with managing gestational weight gain. Barriers may 
include environmental, socioeconomical, emotional, medical or cultural factors, as well 
as physical barriers or physical discomfort (e.g. lack of sleep, mobility issues which may 
hinder participation in daily activities). Practitioners must understand a woman’s cultural 
context to fully understand her behaviours and provide an effective intervention, as 
pregnancy-related health beliefs can be powerful influences on weight gain. Offering 
credible resources and education are essential to improve understanding and weight self-
management. Evidence supports an interdisciplinary team approach for successful weight 
management (Canadian Obesity Network, 2013). Depending on the identified 
complications of excessive weight gain and/or the barriers to weight management during 
pregnancy, providers may include general practitioner, obstetrician, midwife, nurse, 
dietician, exercise physiologist, psychologist and social worker. Given the prevalence of 
excessive weight gain and the subsequent high probability of post-partum weight 
retention, pregnancy is an ever more critical period for obese women. 
1.2.10 Difficulty of Behaviour Change and Obesity 
Various interventions combining physical activity, nutrition and healthy gestational 
weight gain guidelines have been implemented for normal weight women. A large 
number of these intervention studies were unfortunately not successful at reducing mean 
gestational weight gain and preventing excessive gestational weight gain based on IOM 
guidelines. One potential reason that gestational weight gain interventions may have 
success among normal weight women but not obese women is that overweight and obese 
pregnant women may have unique barriers that require a more intensive intervention. 
Many factors that may influence weight gain during an obese pregnancy in particular are 
related to behaviour (energy intake, physical activity), psychological factors (attitude, 
perceived control, intention), sociodemographic issues (age, parity) and physical factors 
(BMI) (Savage et al., 2014).  
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Renault et al. (2014) recently assessed gestational weight gain in obese pregnant women 
using a physical activity intervention with or without dietary intervention. There was no 
significant difference found between the two interventions, and the additive effect of the 
dietary intervention was not significant. Compliance was an issue in the study as a large 
part of the participants did not follow the dietary or physical activity advice. If only 
compliant participants were measured, the weight reduction of the intervention group 
may have been more pronounced. In a review by Pearce et al. (2013), only three 
interventions of the ten randomized control trials included reported statistically 
significant differences between the intervention and control groups. Unfortunately, 
compliance was not consistently reported in the review and it remains unknown if 
participants were adherent to the interventions. Findings suggest that there is little known 
about the efficacy of interventions for obese pregnant women.  
Few interventions have had success specifically targeting gestational weight gain in 
overweight and obese pregnant women. Shirazian et al., (2010) developed a prenatal 
intervention for obese women consisting of six seminars and individual counseling 
sessions promoting healthy eating, walking and obesity education during pregnancy. 
Obese women in the intervention group gained less weight than those in the standard care 
group (8.1 ± 7.4 kg versus 15.3 ± 7.5 kg, p=0.003) (Shirazian et al., 2010). A limitation 
of the study was that physical activity and eating habits were not reported. Shirazian et al. 
(2014) later conducted another intervention revolving around educational and individual 
counseling sessions focused on diet, exercise and weight goals. The free program began 
in the first trimester and consisted of six group seminars, one-on-one counseling and 
telephone calls. Fifty % completion of food diary and pedometer recordings were 
emphasized. The curriculum aimed to educate women on obesity and pregnancy, promote 
healthy eating and encourage walking as exercise. Barriers to a healthy lifestyle were 
addressed and all participants met with a dietician at least once during prenatal care. 
GWG was lower in participants versus control group, though not significant. The number 
of sessions attended was associated with a decrease in total weight gain, demonstrating 
participant attendance is key (Shirazian et al., 2014).  
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Nascimento et al. (2011) conducted weekly aerobic dance classes of moderate intensity, 
with recommendations about weekly physical activity and healthy gestational weight gain 
for both overweight and obese women. A lower mean gestational weight gain was seen in 
the intervention group (10.0 ± 1.7 kg) versus control (16.4 ± 3.9 kg, p=0.001), but only 
for overweight women (Nascimento et al., 2011). Physical activity levels of women in the 
control group were not reported.  
An intervention including only obese women implemented by Claesson et al. (2008) 
focused on behaviour change via motivational interviews and individual counseling 
sessions, and physical activity in the form of aqua aerobic classes 1-2 times per week. 
The intervention group gained less weight (8.7 ± 5.5 kg) compared to the control group 
(11.3 ± 5.8, p <0.001) (Claesson et al., 2008). Seventy-eight % of intervention 
participants actively participated in the counseling sessions and aqua aerobic classes once 
per week.  
McGiveron et al. (2014) developed an intensive health education program around diet 
and exercise, titled the Bumps and Beyond Intervention for obese pregnant women. The 
program offered one-to-one guidance and monitored dietary change while comparing 89 
intervention women to 90 non-intervention women. The intervention group gained less 
weight than the non-intervention group (4.5 kg vs 10.3 kg, respectively). Twenty-one % 
of the intervention group lost weight during pregnancy. Women in the intervention group 
must have attended 7/8 sessions to be included in analysis. The researchers concluded 
that women must perceive the benefits of physical activity and healthy eating to 
ultimately change their lifestyles (increase level of physical activity and reduce unhealthy 
eating) (McGiveron et al., 2014).  
Phelan et al. (2014) conducted behaviour interventions via telephone that targeted 
gestational weight gain, healthy eating and exercise. The intervention increased the 
percentage of women achieving pre-pregnancy weight at 12-months postpartum (35.4% 
vs 28.1%) and significantly reduced the weight retained (1.4 kg vs 3 kg) compared to the 
control group, respectively. Seventy-nine % of participants completed the study through 
12 months postpartum.  
21 
 
In a review of physical activity (PA) and physical activity plus diet interventions in 
managing weight among overweight or obese pregnant women, Choi et al. (2013) 
concluded that PA plus diet interventions are most effective in managing weight 
regardless of body weight status in pregnant women. In addition, Phelan et al. (2011) 
concluded that the best weight control strategies for both non-pregnant and pregnant 
women appears to be the combination of PA and caloric management, with the addition 
of behavioural strategies including frequent self-monitoring of diet and body weight. 
Phelan et al. (2011) examined weight control literature of the past 30 years outside of 
pregnancy to identify the key components of effective programs to potentially apply the 
research to managing weight in the pregnant population. The researchers argue that 
effective weight control strategies outside of pregnancy may also promote better weight 
control and prevent excessive weight gain during pregnancy. The key components of 
effective programs included use of caloric restriction, daily diet self-monitoring, self-
weighing, behaviour therapy and ongoing patient-provider contact. Phelan et al. (2011) 
reported that several clinical trials have found that structured meal plans, which 
simplifies food selection and shopping for patients, improves adherence to calorie goals 
and improves long-term weight loss outcomes. In terms of physical activity in the non-
pregnant population, it was found that long-term results were better in home based 
exercise programs, including the use of pedometers, to improve adherence. Weight 
control literature in the non-pregnant population suggests that daily self-monitoring of 
diet and body weight improves adherence, accountability and motivation.  
In a randomized trial in early pregnancy, Harrison et al. (2014) found regular self-
weighing combined with a self-management intervention optimized weight gain at 28 
weeks gestation (5.66 ± 2.6 kg vs 7.03±3.56 kg) and reduced post-partum weight 
retention (0.57 ± 3.94 kg vs 1.48 ± 5.49 kg) compared with control participants. The self-
management intervention focused on self-directed changes to lifestyle behaviours, goal 
setting and problem solving skills. Intervention participants were encouraged to plot their 
GWG on a chart and self-weigh regularly. 
Research continually suggests that pregnant overweight and obese women require more 
than advice; supervised and personalized programs and goals are needed to prevent 
22 
 
excessive weight gain (Choi et al., 2013). Continued patient-provider contact (≥2 
visits/month) seems to provide patients with the support and motivation required to 
continue to practice weight control behaviours (Phelan et al., 2011A).  
A mild exercise (i.e., walking program) in obese patients is beneficial when used in 
combination with a nutritional program monitoring carbohydrate intake, to limit 
gestational weight gain (Artal et al., 2007). The inclusion of mild exercise is 
advantageous during pregnancy because dietary control alone may reduce not only fat 
mass but also fat-free mass (Mottola et al., 2010). A reduction in fat-free mass in 
combination with a lack of physical activity in obese women may lead to insulin 
resistance, impaired glucose tolerance and possibly GDM (Mottola et al., 2010). As a 
result, Mottola et al. (2010) devised a lifestyle intervention program incorporating both 
dietary control and physical activity to prevent excessive pregnancy weight gain in 
overweight and obese women. The Nutrition and Exercise Lifestyle Intervention Program 
(NELIP), designed at the Exercise and Pregnancy Lab, Western University, London, 
Canada, has since been posted as best practice on the portal website from the Public 
Health Agency of Canada; http://cbpp-pcpe.phac-aspc.gc.ca/interventions/nutrition-
exercise-lifestyle-intervention-program/. NELIP was implemented at 16-20 weeks 
gestation and reduced excessive weight gain with minimal weight retention at 2 months 
postpartum in overweight and obese women, with an 80% success rate (Mottola et al., 
2010). It has been shown that pregnancy weight gain during the first 20 weeks of 
gestation is predictive of total weight gain (Polley et al., 2002).  Therefore, it may be 
possible to identify women in early pregnancy that may be at risk for exceeding weight 
gain recommendations, allowing for early nutrition and exercise counseling and 
interventions (Polley et al., 2002). It would be advantageous to begin the intervention 
earlier in gestation (12-16 weeks rather than 16-20) to prevent excessive weight gain 
(Mottola et al., 2010).  
Ultimately, there is limited research on gestational weight gain control in obese (class 
2/3) women. Literature suggests that pregnant women of normal BMI are often highly 
motivated to make lifestyle changes, thus pregnancy provides an ideal time to initiate a 
lifestyle intervention program. It is unknown if this remains true for obese women. 
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Research supports a multidisciplinary team approach of health care providers to improve 
care for obese pregnant women, who have unique and challenging barriers. Behavioural, 
psychological and physical barriers discussed previously may require a more intensive 
intervention. Literature routinely suggests that the best weight control strategy for both 
nonpregnant and pregnant women alike is a combination of PA and a dietary 
intervention. However, as previously mentioned, Renault et al. (2014) found that the 
additive effect of a dietary intervention on top of a PA intervention was not significant in 
controlling excessive GWG in obese pregnant women, contrary to what one would 
expect. While dietary control and physical activity is an ideal combination to prevent 
excessive GWG, it may not be a practical solution for obese pregnant women. Perhaps 
pregnancy is not the ideal time to make intensive lifestyle changes in the obese 
population because of the unique barriers these women face. Obese women may have 
difficulty with two behaviour changes (healthy nutrition and increased exercise 
simultaneously) and may find one lifestyle change easier to achieve (either nutrition or 
exercise) than both of these behaviour changes at the same time. The current pilot study 
has been designed to investigate how to better manage GWG and pregnancy outcomes 
for class 2/3 obese pregnant women.  
Objectives of the current pilot trial include assessing feasibility, exploring the practical 
application for a pivotal randomized controlled trial, and evaluating the logistics of the 
trial (Loscalzo, 2009). Results obtained may be used to optimize the design in subsequent 
studies, and may help guide the effective use of limited (financial and non-financial) 
resources essential for a successfully performed intervention in the future (Loscalzo, 
2009).  
 
 
 
24 
 
Chapter 2  
2 Purpose 
The primary purpose of the current pilot study was to investigate the efficacy of an 
evidence-based laboratory program, known as the Nutrition and Exercise Lifestyle 
Intervention Program (NELIP), in the clinical setting. The specialized clinical setting 
chosen was “My Clinic” located at the London Health Sciences Centre (LHSC) that 
provides specialized care for those women with a pre-pregnancy BMI of ≥ 35 kg/m2 and 
who have an increased obstetric risk for complications. A secondary purpose was to 
determine if a specialized clinic improved outcomes for obese pregnant women in 
London, Ontario.  
Advanced care at My Clinic includes twice monthly clinic visits, additional ultrasounds 
for fetal assessment and oral glucose tolerance tests at first visit (extra), 28 weeks 
(usually done between 24 and 28 weeks) and 34 (extra) weeks gestation. These extra 
visits, assessments and tests are not routinely done in standard care. My Clinic care uses a 
team approach offering patients specialized obstetrical care, social work, and the 
expertise of a dietician and a kinesiologist. Patients of My Clinic have regular meetings 
with a dietician on staff where they receive education on Canada’s Food Guide and 
healthy eating tips. A social worker and kinesiologist are available for patients if deemed 
appropriate or beneficial.  
To determine if My Clinic care improved pregnancy outcome measures in women with 
class 2/3 obesity, those receiving My Clinic standard care were compared to a sanitized 
(no personal information) perinatal database (receiving no specialized obstetric care) 
containing information on birth outcomes in the City of London.  The perinatal database 
was analyzed to determine whether maternal obesity class 2 and 3 (pre-pregnancy BMI 
≥35 kg/m2) is an issue regarding perinatal outcomes compared to those women with a 
pre-pregnancy BMI < 35 kg/m2 that may necessitate specialized obstetrical clinic care. 
Rates of obesity and birth outcomes for women who delivered a singleton baby in 
London were evaluated.  
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In order to examine the efficacy of the NELIP in the My Clinic clinical setting, women 
recruited from My Clinic were randomized into one of three groups: 1) Women who 
received the full NELIP; 2) Women who received only the nutrition component of 
NELIP; or 3) Women who received only the exercise component of NELIP. GWG and 
pregnancy outcomes were compared between the three groups and to those women 
receiving standard care from My Clinic who did not want to be randomized but were 
willing to provide their clinic data for analyses. Comparing these three randomized 
groups to standard care at My Clinic also justified if an additional intervention (either full 
NELIP, Nutrition only or Exercise only) was necessary in addition to standard care at the 
specialized clinic to help prevent excessive GWG and to assess the resultant pregnancy 
outcomes. Comparison of the three randomized groups determined if one behaviour 
change (Nutrition alone or Exercise alone) is more efficacious for obese pregnant women 
than two behaviour changes (full NELIP) in preventing excessive GWG. 
2.1 Hypotheses 
1. It was hypothesized that women receiving standard care at My Clinic would have 
better outcome measures; decreased incidence of macrosomia (babies born >4.0 
kg), small birth weight babies (<2.5 kg) and pregnancy complications than those 
not receiving specialized standard care at My Clinic (perinatal database). 
Pregnancy complication was defined by the number of Caesarean sections (yes or 
no). 
2. It was hypothesized that women receiving full NELIP at My Clinic would have 
better success in preventing excessive GWG, reduction in macrosomia, small 
birth weight babies, and pregnancy complications than those receiving Nutrition 
alone, Exercise alone, or standard care at My Clinic. 
 
26 
 
Chapter 3  
3 Methodology 
3.1 Perinatal Database 
Ethics approval from the Human Research Ethics Boards for Health Sciences at Western 
University and the London Health Science Centre was obtained (Appendix A1) for 
analyzing the sanitized perinatal database from medical records containing maternal 
characteristics and perinatal outcomes for all singleton births in London, Canada between 
January 1 and December 31, 2011. Women with incomplete data (i.e., lacking height, or 
pre-pregnancy weight), smokers, drug users, and those who consumed alcohol were 
removed from the dataset. Women diagnosed with type 1 and type 2 diabetes prior to 
pregnancy, and those who developed GDM were also removed from the data set. The 
remaining women defined the perinatal database and were stratified by those with a pre-
pregnancy BMI<35 and those with a BMI ≥35 kg/m2. Those women meeting study 
inclusion criteria with a BMI ≥ 35 kg/m2 were used as a matched cohort control group. 
Caesarean section (yes/no) and infant birth weight were recorded. However, maternal 
gestational weight gain was not available in the dataset.  
3.2 Standard Care Procedure at My Clinic 
Standard care My Clinic patients completed a self-reported Weight and Health History 
Questionnaire (Appendix A2) during their initial visit to the clinic. From this 
questionnaire, self-reported pre-pregnancy weight was recorded from the patient file. 
Height was measured and also recorded in the patient file. All women were medically 
pre-screened by their obstetrician for contraindications to physical activity using the 
PARmed-X for Pregnancy (2013; Appendix A3). The height and pre-pregnancy weight 
measurements were used to calculate pre-pregnancy BMI (kg/m)2. My Clinic patients had 
appointments in the clinic every two weeks on average. Weight was charted at each visit 
to monitor rate of weight gain as well as total gestational weight gain. Patients received 
three fasted oral glucose tolerance tests (OGTT) throughout their pregnancy. All women 
who had no contraindications to physical activity were approached to participate in the 
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randomized control trial (RCT; see below) and those women who did not wish to 
participate in the RCT (see below) signed informed consent (Appendix A4) to be 
considered as the My Clinic standard care group. Those in My Clinic standard care were 
offered Canada’s Food guide and healthy eating tips but did not receive a structured meal 
plan from dietician. Those receiving My Clinic standard care were encouraged to exercise 
by their obstetrician but were not given a formal exercise program.  
3.3 My Clinic Randomized Controlled Trial 
Women were recruited for the pilot RCT from My Clinic standard care patients who met 
the above criteria. The Human Research Ethics Boards for Health Sciences at Western 
University and the London Health Science Centre approved the RCT protocol (Appendix 
A1), and all women gave informed written consent to participate in the RCT. This trial 
was registered at www.clinicaltrials.gov, NCT02155751. 
3.3.1 Participants 
Women over the age of 18 years, with a pre-pregnancy BMI of ≥ 35 kg/m2 (class 2 and 3 
obese), between 12 and 20 weeks gestation were recruited to participate in the study 
through self-referrals and family physician referrals to My Clinic. In order to participate 
in the study, women had no contraindications to walking, did not have type 1, type 2 
diabetes, or GDM at baseline, and were nonsmokers.  
3.3.2 Randomization 
CONSORT (Consolidated Standards of Reporting Trials) guidelines were followed to 
generate the random allocation sequence using a random numbers table. CONSORT 
ensures proper design and execution of the RCT to avoid bias or exaggerated treatment 
effects (Moher et al., 2012). The SNOSE (sequentially numbered, opaque sealed 
envelopes) (Doig & Simpson, 2005) method was chosen for random allocation to the 
different treatment groups: full NELIP, Nutrition only or Exercise only.  
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3.3.3 Intervention Procedure at My Clinic 
If patients did not have GDM at their initial fasted OGTT at 12-20 weeks gestation, they 
were eligible to participate in the study. Following consent, each participant completed a 
3-day food intake record (Appendix A6) and a 7-day pedometer log (Appendix A7) for 
baseline measurements. The 3-day food intake records were analysed for nutritional 
information (total energy per day and daily macronutrient intake) using a nutrition 
program (ESHA Food Processor SQL software). Once the 3-day food intake record and 
the pedometer log sheets were collected, the women were assigned at random to one of 
the study groups (full NELIP, Nutrition-only, or Exercise-only). 
Participants assigned to the Nutrition-only component of NELIP were taught a specific 
meal plan (Appendix A8) by the My Clinic dietician (trained in the NELIP protocol) to 
promote healthy eating habits, regulate blood sugar levels and control excessive GWG. 
The dietary program was similar to the gestational diabetic meal plan designed to: a) 
individualize total energy intake with a minimum of 2000 kcal/day (8360 kJ/day), taking 
into account the usual energy intake as indicated by each dietary assessment (including 3-
day food intake record) with a restriction of not more than 33% total energy intake; b) 
adjust if necessary the total carbohydrate intake to 40-50% of total energy intake, 
distributing carbohydrate intake throughout the day with three balanced meals, and three 
snacks per day emphasizing complex carbohydrates and low glycemic index foods; c) 
adjust the total fat intake to 30% of total energy intake (substituting monounsaturated 
fatty acids for saturated and trans-fatty acids), with the remaining 30% dedicated to 
protein intake; and d) meet all micronutrient and fluid needs recommended during 
pregnancy (Mottola et al. 2010).  
Participants in the Nutrition-only group recorded their 24-hour food and drink intake 
once per week and met with the dietician at each clinic visit to determine whether 
adjustments in the nutrition program were required as pregnancy progressed. These 
weekly food intake logs were handed in to the dietitian and analysed using the ESHA 
Food Processor SQL software. Women in this group were given no formal exercise 
advice, (except to be active as standard care for the women in My Clinic), no pedometer 
to record steps, and no exercise self-monitoring during the intervention. 
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Participants assigned to the Exercise-only component of NELIP began a controlled 
walking program. Participants walked for 25 minutes per session, 3 to 4 times per week, 
adding 2 minutes each week to the session until 40 minutes was reached and then 
maintained until delivery (Mottola et al. 2010). Daily steps were recorded using a 
pedometer and log sheet (Appendix A7) to keep track of daily steps and to initiate self-
monitoring behaviour. An easy and maintainable walking pace was encouraged to avoid 
becoming breathless. Participants had the option of attending the clinic once per week for 
a monitored walk with an exercise specialist, or completing walks at home (whether that 
be on a treadmill, an outdoor trail, in their neighbourhood, etc.). Pedometer log sheets 
were handed in to the exercise specialist at each clinic visit. As part of standard care at 
My Clinic the participants in the Exercise-only group met with the clinic dietitian at each 
scheduled My Clinic visit and were given information on Canada’s Food Guide and 
healthy eating tips. These women did not receive the NELIP meal plan, nor did they 
complete or record (self-monitor) their food intake. 
Participants assigned to the full Nutrition and Exercise Lifestyle Intervention Program 
(NELIP) were introduced to both the dietary and walking program, including the self-
monitoring for both nutrition and exercise, described above.  
All participated in the programs from 12-20 weeks until delivery and were weighed at 
each visit to the clinic, on average twice monthly, similar to standard care at My Clinic. 
Infant birth weight, APGAR scores and pregnancy and/or delivery complications were 
obtained from medical charts. Within 6-18 hours after birth (before the women left the 
hospital), a member of the research team visited the participant in hospital and measured 
the length of the newborn within 0.1 cm and recorded all other birth information from the 
chart.  
3.4 Outcome Measurements 
Maternal anthropometric measurements were taken from each patient’s chart and 
included height (cm), pre-pregnancy weight (kg), and last measured weight prior to 
delivery (kg) to calculate gestational weight gain (weight prior to delivery (kg) – pre-
pregnancy weight (kg)). Total gestational weight gain (kg) and rate of weight gain 
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(calculated per week) were used to determine whether there was a significant difference 
between the three NELIP groups and those receiving standard care at My Clinic.  
The incidence of macrosomia was assessed as the number of babies born >4.0 kg (Artal 
et al., 2007). Macrosomia incidence rates were compared between the three groups of 
NELIP women vs. My Clinic standard care women, and those not receiving My Clinic 
care (information from the London, ON perinatal database).  
Pregnancy complications were also assessed between the three groups of NELIP women, 
My Clinic standard care, and the perinatal database. Pregnancy complication was defined 
as Caesarean section (yes/no). 
3.5 Statistical Analyses 
Participant characteristics were compared between the perinatal database, My Clinic 
specialized standard care, and My Clinic NELIP participants (that also received the My 
Clinic specialized standard care). Continuous data (i.e. maternal height, maternal pre-
pregnancy weight, maternal pre-pregnancy BMI, maternal gestational weight gain, infant 
weight) were compared using an ANOVA. ANOVA and Student’s t-tests were used to 
compare pedometer step-counts and nutrition data between the three randomized groups 
at baseline and to compare pre data to data collected while on the intervention for each 
individual group. Data were presented as mean ± standard deviation. Categorical infant 
data (small birth weight (yes/no), macrosomia (yes/no), C-section rate (yes/no)) were 
compared using a chi-squared test. Statistical significance was set at p≤0.05.   
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Chapter 4 
4 Results 
4.1 Perinatal Database 
A total of 4565 women were removed from the dataset due to incomplete data (i.e., 
lacking height, or pre-pregnancy weight), smokers (N=139), drug users (N=76), and 
those who consumed alcohol (N=25) and women diagnosed with type 1 and type 2 
diabetes prior to pregnancy (N=8), leaving 834 women for the final analysis. A total of 
39 women developed GDM during pregnancy (approximately 5%) (N=23 GDM diet 
controlled, N=13 GDM insulin controlled, N=3 no information how they controlled their 
GDM) and were also removed from the dataset for final analyses. Interestingly, the mean 
pre-pregnancy BMI for those that developed GDM was 31.3 ± 6.6 kg/m2. Twenty-six % 
of those that developed GDM had a BMI ≥ 35 kg/m2 (N=10).  
Average birth weight for all infants born to mothers of all BMI classifications in the 
perinatal database (N=834) was 3.4 ± 0.6 kg. Average gestational age was 38.6 ± 2.4 
weeks. Macrosomia (>4.0 kg birth weight) incidence for mothers of all BMI 
classifications was 14% (N=117). Small birth weight (<2.5 kg) incidence was 8% 
(N=69). The Caesarean section rate for mothers of all BMI categories was 27.8% 
(N=232).  
The remaining women (N=834) were stratified by BMI<35 (N=787) and ≥35 kg/m2 
(N=47). The 47 women meeting study inclusion criteria with a BMI ≥ 35 kg/m2 were 
used as a matched control group to My Clinic participants.  
The women in the matched control group were 30.9 ± 4.1 years old, 164 ± 6.6 cm tall, 
with a pre-pregnancy body mass of 106.5 ± 15.0 kg and a pre-pregnancy BMI of 39.2 ± 
4.4 kg/m2. Average infant birth weight was 3.5 ± 0.8 kg, while gestational age was 38.4 ± 
2.5 weeks. Maternal gestational weight gain was unfortunately not included in the 
database. Macrosomia incidence was 27.7% (N=13). Small birth weight incidence was 
6.4% (N=3).  
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Chi-square analysis revealed a difference in macrosomia incidence between the women 
in the perinatal database with a pre-pregnancy BMI of ≥ 35 kg/m2 (27.7%) and those 
women with a BMI of < 35 kg/m2 (12.6%; p=0.03). The rate of small birth weight babies 
for women with a pre-pregnancy BMI of ≥ 35 kg/m2 (6.4%) did not differ from those 
women with a BMI of < 35 kg/m2 (7.6%; p=0.58). 
The Caesarean section rate for infants of mothers with a BMI ≥ 35 kg/m2 was 40.4% 
(N=19), while the Caesarean section rate for infants of mother’s with a BMI <35 kg/m2 
was 22.4%; p=0.007. For those with a BMI ≥ 35 kg/m2 there were three cases of forceps 
deliveries (6%) and one vacuum delivery (2%). Five infants (10.6%) had fetal 
complications and were admitted to the Neonatal Intensive Care Unit (NICU). For those 
with a BMI <35 kg/m2 there were 59 cases of forceps deliveries (7.5%) and 24 cases of 
vacuum deliveries (3%), and 114 (13.1%) had fetal complications and were admitted to 
the NICU. 
4.2 My Clinic Standard Care vs Perinatal Database 
Twenty-one women consented to be included as patients representing standard care for 
My Clinic. The women were 30.8 ± 7.1 years old, 165 ± 6.2 cm tall, with a pre-pregnancy 
body mass of 123.1 ± 23.2 kg and a pre-pregnancy BMI of 45.2 ± 7.3 kg/m2. Average 
infant weight was 3.4 ± 0.5 kg, while gestational age was 38.7 ± 1.4 weeks. Average 
parity for this group was 0.9 ± 1.4. Macrosomia incidence was 5.3% (N=1) and there 
were no cases of small birth weight infants.  
Chi-square analysis revealed a difference in macrosomia incidence between My Clinic 
standard care (5.3%) and perinatal database women with a pre-pregnancy BMI ≥ 35 
kg/m2 (27.7%; p=0.000), and standard care was not different than those women from the 
perinatal database with a BMI < 35kg/m2 (12.6%; p=0.112). There was a significant 
difference in small birth weight babies between My Clinic standard care and the perinatal 
database (none vs 6.4%, respectively; p=0.000). The Caesarean section rate for infants 
born to mothers of My Clinic standard care was 38% (N=8), and was not significantly 
different than the Caesarean section rate of the women in the perinatal database with a 
pre-pregnancy BMI ≥ 35 kg/m2 (see Table 3).  
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Table 3 My Clinic standard care women compared to women in the Perinatal 
Database with a pre-pregnancy body mass index of ≥35 kg/m2  
Group Birth 
Weight 
(kg) 
Birth 
Length 
(cm) 
C-section 
(#/%) 
Macrosomia 
(#/%) 
Small birth 
weight (#/%) 
My Clinic 
Standard Care 
N=21 
3.4 ± 0.5 N/A 8/38.1% 1/5.3%† 
 
 
0/0%** 
Perinatal 
Database N=47 
3.5 ± 0.8 N/A 19/40.4% 13/27.7% 
 
3/6.4% 
Birth length was not available 
† My Clinic standard care vs perinatal database ≥ 35 kg/m2, p=0.000 
** My Clinic standard care vs perinatal database ≥ 35 kg/m2, p=0.000 
Total gestational weight gain for the My Clinic standard care group was 7.6 ± 7.1 kg, 
within the IOM’s 2009 recommendations for obese women (IOM, 2009). Weight gain 
prior to the first appointment at My Clinic was 1.8 ± 8.8 kg. Women received My Clinic 
standard care for 20.0 ± 8.8 weeks. Weight gain while attending the clinic was 6.4 ± 4.9 
kg, while the rate of weight gain was 0.4 ± 0.4 kg/week. Fifty-five % of the women 
gained excessive weight while receiving My Clinic care (N=12). For four of these women 
(33%), excessive weight gain occurred prior to their first appointment at My Clinic at 
18.1 ± 5.9 weeks gestation.  
4.3 My Clinic Intervention (RCT) 
A total of 26 women were recruited to participate in the RCT and signed consent 
(Appendix A5). Three women developed GDM prior to 20 weeks gestation, before 
randomization, and were removed from the study (exclusion criteria). Eleven women 
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withdrew from the study prior to randomization. Twelve women agreed to participate and 
met the inclusion criteria (see Figure 1). They were randomized into one of three groups. 
Four women were allocated to the nutrition only group, and one dropped due to the 
severity of her Crohn’s disease flare ups with the meal plan. Five women were allocated 
to the exercise only group, and two dropped due to the required time commitments. Three 
women were allocated to the full NELIP and all withdrew due to a combination of 
factors, including pain when exercising, leaving My Clinic care for midwifery care, and 
the time commitments required, resulting in a drop out rate of 100%. Ultimately, only 6 
women in total completed the program for the entire duration of pregnancy. 
 
Figure 1: Randomization flow chart for My Clinic research patients 
1 GDM – gestational diabetes mellitus  
Baseline data consisting of a three-day food intake record (Table 4) and seven-day 
pedometer log (Table 5) were collected for the RCT women. There was no statistical 
difference between the groups at baseline.  
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Table 4 Baseline data: Average daily three-day food intake record data for 
participants (N=6) prior to randomization. 
Group Total  
Energy 
(kcal) 
PRO 
(g) 
CHO 
(g) Fat (g) 
% 
Protein 
% 
CHO 
% 
Fat 
Participants 
(N=6) 2535.6 ± 
1286.5 
93.8 ± 
36.3 
321.0 ± 
159.5 
102.2 ± 
70.4 
14.6 ± 
3.7 
47.8 ± 
9.7 
37.6 ±  
9.1 
Nutrition-
only (N=3) 3385.5 ± 
1871.7 
122.9 ± 
45.4 
411.25 
± 185.1 
148.45 ± 
112.1 
12.5 ± 
0.7 43 ± 4.2 
44.5 ± 
5.0 
Exercise-
only (N=3) 1969 ± 
595.7 
74.5 ± 
14.2 
260.9 ± 
142.0 
71.4 ± 
8.9 16 ± 4.4 
51 ± 
11.8 
33 ± 
8.7 
PRO – protein  
CHO – carbohydrate 
No statistical difference between the groups at baseline 
Table 5 Baseline data: Average daily step counts from seven-day pedometer record 
for participants prior to randomization.  
Participants (N=6) 6340.1 ± 2443.7 
Nutrition-only (N=3) 7167.5 ± 4532.8 
Exercise-only (N=3) 5895.6 ± 628.9 
No statistical difference between the groups at baseline. 
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The six women who completed their respective intervention program were 31.3 ± 5.4 
years old, 164.3 ± 5.9 cm tall, with a pre-pregnancy body mass of 123.3 ± 18.6 kg and a 
pre-pregnancy BMI of 44.1 ± 5.5 kg/m2. Infant weight was 3.51 ± 0.55 kg, and infant 
length was 52.6 ± 4.8 cm, while gestational age was 38.8 ± 2.9 weeks. The incidence of 
macrosomia (>4.0 kg) for infants of My Clinic intervention participants was 15% (N=1). 
There were no cases of small birth weight infants (<2.5 kg). Two women had C-sections 
(33.3%), and one woman had a forceps delivery. One infant of an intervention participant 
(N-only) had fetal complications and as a result was admitted into NICU.  
Average parity was 1.0 ± 2.4. Total gestational weight gain for intervention participants 
was 7.5 ± 10.6 kg, within the IOM guidelines for obese women (IOM 2009). An average 
weight loss of 1.2 ± 5.5 kg occurred prior to beginning the intervention at 12-20 weeks 
gestation. Weight gain on the 20.6 ± 2.9 week long intervention was 7.5 ± 10.6 kg, while 
the rate of weight gain was 0.38 ± 0.27 kg/week. Fifty % of the women did not gain 
excessive weight (N= 3). Fifty % gained excessively (N=3), and for two of these women, 
excessive weight gain occurred prior to beginning the intervention at 16-20 weeks 
gestation. If excessive weight was not gained prior to the intervention the success rate 
would increase from 50% to 83%. 
The 3 women who participated in the Nutrition-only intervention were 27.0 ± 3.0 years 
old with a pre-pregnancy body mass of 127.1 ± 26.5 kg and a pre-pregnancy BMI of 46.2 
± 7.4 kg/m2. Infant birth weight was 3.64 ± 0.6 kg, infant length was 52.4 ± 4.0 cm, 
infant BMI was 13.2 ± 0.7, and gestational age was 39.7 ± 1.2 weeks. Total gestational 
weight gain was 14.6 ± 5.7 kg, above the IOM guidelines for obese women (IOM 2009). 
The rate of weight gain during the intervention was 0.6 ± 0.1 kg/week. The drop-out rate 
for the Nutrition only intervention was 25% (1/4). The average nutritional data (Table 6) 
revealed a significant increase (p=0.04) in % of total energy intake from protein between 
baseline food intake records and records obtained during the ongoing Nutrition-only 
intervention. The % of calories from fat did not change while following the meal plan, 
however there appeared to be a reduction of 36% compared to baseline records (p=0.07).  
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Table 6 Average nutrition data at baseline compared to the Nutrition-only 
intervention at the end of the program 
 Total 
Energy 
(kcal) 
PRO 
(g) 
CHO 
(g) Fat (g) 
% 
Protein 
% 
CHO % Fat 
Pre-
intervention 
(baseline) 
3385.5 
± 
1871.7 
122.9 ± 
45.4 
411.3 ±  
185.1 
148.5 ±  
112.1 
12.5 ±  
0.7 43 ± 4.2 
44.5 ±  
5.0 
Nutrition-only 
intervention 
1769.9 
± 27.3 
90.55 ± 
1.3 
232.2 ± 
22.9 
56.45 ± 
13.7 20 ± 0* 
51.5 ± 
6.4 
28.5 ± 
6.4** 
Effect size 0.52 0.45 0.56 0.49    
* Intervention different from baseline, p=0.04 
** p=0.07 
Medium effect size = 0.3 - 0.5 
The three women who participated in the Exercise only intervention were 35.7 ± 2.9 
years old with a pre-pregnancy body mass of 119.5 ± 10.8 kg and a pre-pregnancy BMI 
of 42.0 ± 3.0 kg/m2. Infant birth weight was 3.4 ± 0.6 kg, infant length was 52.2 ± 5.7 
cm, infant BMI was 12.4 ± 1.2, and gestational age was 38.0 ± 3.6 weeks. Total 
gestational weight gain in the exercise only intervention was 0.4 ± 9.9 kg (within the 
IOM guidelines; IOM, 2009). The rate of weight gain during the intervention was 0.2 ± 
0.1 kg/week. The drop-out rate for the exercise only intervention was 40% (2/5). 
Participants doubled their daily step counts (Table 7), though not significant (p=0.18).  
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Table 7 Average daily step counts at baseline compared to Exercise-only 
intervention at the end of the program 
Pre-intervention (baseline) 5895.6 ± 628.9 
Exercise-only intervention 11900.8 ± 2659.8  
Effect size 0.84  
No statistical difference between baseline and Exercise-only intervention 
Large effect size = ≥ 6.0 
Although there was no significant difference in average total weight gain between the 
groups (see Table 8), there was a difference trending towards significance (p=0.09) 
between the My Clinic Exercise-only group (0.4 ± 9.9 kg) compared to the Nutrition-only 
(14.6 ± 5.7 kg) group. The average rate of weight gain was significantly less in the 
Exercise-only group (0.2 ± 0.1 kg/week) compared to both My Clinic standard care (0.4 ± 
0.4 kg/week; p=0.04) and the Nutrition-only (0.6 ± 0.1; p=0.01) groups.   
Birth weight was not different between the groups (see Table 9). Chi-square analysis 
failed to find a difference in C-section rates between patient groups from My Clinic.  
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Table 8 Characteristics of women receiving Standard Care at My Clinic compared 
to women receiving the intervention (Exercise only; E-only, or Nutrition only; N-
only) 
Group Pre-
pregnancy 
weight (kg) 
Pre-
pregnancy 
BMI 
(kg/m2) 
Age 
(years) 
Total 
Weight 
Gain (kg) 
Rate of 
Weight 
Gain 
(kg/week) 
Gestational 
Age 
(weeks) 
My Clinic 
Standard 
Care 
N=21 
123.1 ± 
23.2 
45.2 ± 7.3 30.8 ± 
6.9 
7.6 ± 7.1 0.42 ± 
0.43‡ 
38.7 ± 1.4 
My Clinic 
NELIP 
E-only 
N=3 
119.5 ± 
10.8 
42.0 ± 3.0 35.7 ± 
2.9+ 
0.42 ± 
9.9** 
0.2 ± 0.1* 38.0 ± 3.6 
 
 
My Clinic 
NELIP    
N-only 
N=3 
127.1 ± 
26.5 
46.2 ± 7.4 27.0 ± 
3.0 
14.6 ± 5.7 0.6 ± 0.1 39.7 ± 1.2 
+ E-only different from N-only, p=0.02 
* E-only different from N-only, p=0.01; **p=0.09 
‡ Standard Care different from E-only, p=0.04. 
NELIP – Nutrition and Exercise Lifestyle Intervention Program 
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Table 9 Summary of weight gain between My Clinic groups and perinatal outcomes 
between all groups 
Group Total 
Weight 
Gain (kg) 
Rate of 
Weight 
Gain 
(kg/week) 
C-section 
(#/%) 
Macrosomia 
(#/%) 
Small birth 
weight (#/%) 
Perinatal 
Database 
N=47 
N/A N/A 19/40.4% 13/28% 
 
3/6.4%+ 
My Clinic 
Standard 
Care 
N=21 
7.6 ± 7.1 0.4 ± 0.4‡ 8/38.1% 1/5.3%†† 
 
 
0/0% 
My Clinic 
NELIP          
E-only 
N=3 
0.4 ± 9.9** 0.2 ± 0.1* 1/33.3% 0/0% 0/0% 
My Clinic 
NELIP          
N-only 
N=3 
14.6 ± 5.7 0.6 ± 0.1 1/33.3% 1/33.3% 0/0% 
* E-only different from N-only, p=0.01; **p=0.09 
‡ Standard Care different from E-only, p=0.04 
†† My Clinic standard care different from perinatal database ≥ 35 kg/m2, p=0.02 
+ My Clinic standard care different from perinatal database ≥ 35 kg/m2 vs E-only vs N-
only p=0.000 
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Chapter 5 
5 Discussion 
For women with a pre-pregnancy BMI of ≥ 35 kg/m2 who were referred to a specialized 
clinic (My Clinic) an intervention consisting of exercise only was better at preventing 
excessive gestational weight gain than a nutrition intervention alone. Combining a 
nutrition and exercise intervention appeared difficult for this population as 100% of the 
women randomized to this group dropped out (although one woman changed to 
midwifery care). It may be that the combination of a nutrition and exercise program 
requiring two lifestyle behaviour changes (eating habits and physical activity) may be a 
burden for this specialized group of obese women. Changing one behaviour, specifically 
the addition of a walking program appeared to be best for this population group, as these 
women were able to prevent excessive gestational weight gain. Standard care at My 
Clinic appeared to reduce macrosomia rates and no babies were born small compared to 
women with similar BMIs matched from the perinatal database. 
5.1 Is there a need for My Clinic care? 
Literature indicates that both patients and health care practitioners express a need for a 
well-rounded approach to obesity and weight management (Forman-Hoffman et al., 
2006). Increased ease of access to a multidisciplinary team of health care providers will 
benefit patients and physicians alike. Few primary care clinicians are regularly 
counseling obese patients on weight management, as many lack the proper training in the 
management of obesity as a whole, and more specifically, maternal obesity (Forman-
Hoffman et al., 2006). McDonald et al., (2011) reported that few pregnant women were 
counseled by their primary care physician according to the 2009 IOM weight gain 
guidelines, and advised of the risks associated with excessive GWG. Only 28.5% of the 
women in the sample survey at prenatal clinics reported their health care provider made 
weight gain recommendations, while only 25% were made aware of the risks of 
inappropriate or excessive weight gain.  Despite the 2009 publication of the GWG 
guidelines, only 12% of women reported being counseled correctly on weight gain 
according to the IOM recommendations (McDonald et al., 2011). These statistics reveal 
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an urgent need for improved patient care, especially in the obese population where the 
risks associated with excessive GWG are even greater. In recognition of this, the 
Canadian Obesity Network (2013) developed the ‘5 A’s of Healthy Pregnancy Weight 
Gain’ as an education tool for health care practitioners to better manage obese pregnant 
women. The program advises physicians to follow the 2009 IOM weight gain guideline 
recommendations, and identify and discuss the root cause(s) of the patient’s obesity as 
well as the barriers associated with managing GWG. An essential element of the 
Canadian Obesity Network is patient education to improve self-management. The 
Canadian Obesity Network concludes that evidence supports a multidisciplinary team 
approach for successful weight management. Many of the recommendations from the ‘5 
A’s’ have been purposefully adopted in My Clinic to better manage weight gain in the 
pregnant obese population. 
The model of behavior change, known as the Stages of Change (SOC) model, states that 
individuals can be characterized as belonging to one of five ‘stages’ in respect to 
changing chronic behavior patterns (Prochaska & Di Clemente, 1985). In pre-
contemplation the individual does not intend to change their behaviour in the next six 
months. An individual in the contemplation stage is strongly inclined to change 
behaviour in the next 6 months. Preparation is characterized by an individual’s intention 
to act in the near future (generally the next month). In the action stage the behaviour has 
already been incorporated for at least six months. The individual incorporating the 
behaviour for more than six months characterizes the maintenance stage, where the 
likelihood of the old behaviour returning is low.  
Literature supports interventions tailored to an individual’s specific stage of change to 
improve effectiveness (Prochaska & Goldstein, 1991). My Clinic standard care aimed to 
assist and guide women through the stages of change by implementing the 5 A’s of 
healthy pregnancy weight gain and obesity management into standard care (Canadian 
Obesity Network, 2013).  The majority of women referred to My Clinic began in the pre-
contemplation stage. In attempt to guide women into the contemplation stage 
obstetricians first asked for patient permission to discuss patient’s current weight and 
healthy pregnancy weight gain. The risks associated with the patient’s BMI and 
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pregnancy were then assessed and communicated (advised). The benefits of a healthy 
lifestyle were discussed with an emphasis on improving overall pregnancy outcomes for 
both mother and baby. If the patient was ready to transition into the preparation stage, 
realistic goals for appropriate pregnancy weight gain were discussed in a positive manner 
and agreed upon in attempt to avoid patient self-disappointment and non-adherence. The 
preparation stage also involved the obstetrician assisting the patient, which included but 
was not limited to a dietician referral, exercise specialist referral, more frequent follow-
up appointments, educational resources, etc.  
The lack of training among primary care practitioners combined with the increasing 
prevalence of maternal obesity justifies the need for My Clinic to better service obese 
pregnant women. A team approach used at My Clinic was shown to better manage 
obesity treatment and prevention than those not receiving the specialized My Clinic care 
(perinatal database).  
Analysis of the perinatal database determined that maternal obesity is an issue in London, 
Canada, with an obesity rate of 18%. Six % of all pregnancies belonged to class 2/3 obese 
women, necessitating specialized obstetrical care. Moreover, this 6% did not include 
class 1 obese women nor class 2/3 obese women with GDM (as it was an exclusion 
criteria), which would increase the percentage of obese pregnant women. It is concerning 
that current evidence reveals that up to 72% of obese women have excessive GWG 
according to current IOM recommendations (Faucher and Barger, 2015). There was a 
marked difference between macrosomia incidence between the women in the perinatal 
database with a pre-pregnancy BMI of ≥ 35 kg/m2 (27.7%) and those women with a BMI 
of < 35 kg/m2 (12.6%), further justifying the need for more intensive obstetrical care. 
Similarly, women in the perinatal database with a BMI ≥ 35 kg/m2 also had an increased 
Caesarean section rate (40%) compared to women with a BMI <35 kg/m2 (23%).  
While My Clinic standard care did not impact Caesarean section rates compared to the 
perinatal database, rate of macrosomia (5.3% vs. 28%) and rate of small birth weight 
infants (0% vs 6.4%) were reduced. Evidence over the long term has demonstrated that 
macrosomia and small birth weight can lead to an increased risk of infants later 
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developing metabolic syndrome and childhood obesity (Guelinckx et al., 2008). If My 
Clinic care can decrease rates of macrosomia and small birth weight babies it may 
potentially slow down the vicious cycle of obesity, diabetes and metabolic syndrome over 
future generations. It is evident that My Clinic standard care played an important role in 
delivering healthier babies of class 2/3 obese pregnancies compared to women who did 
not receive the specialized obstetrical care (perinatal database). 
5.2 NELIP – Did it work? 
The second major objective of the present study was to determine if an evidenced-based 
Nutrition and Exercise Lifestyle Intervention Program (NELIP) was an effective addition 
to My Clinic standard care. Furthermore, the current study aimed to determine whether 
one behaviour change (Nutrition alone or Exercise alone) would be a more realistic 
intervention for class 2/3 obese pregnant women compared to two behaviour changes 
(full NELIP). Considering the drop-out rate for the full NELIP was 100%, even though 
NELIP is best practice, the full intervention may be too difficult for class 2/3 obese 
women in the clinical setting. Adhering to a meal plan and recording food intake while 
simultaneously incorporating and recording daily exercise may be too challenging and 
ultimately may have led to withdrawal from the full intervention. Although one woman 
switched to midwifery care, the other two women cited pain upon exercise and too great 
of a time commitment.  
Campbell et al. (2011) conducted a review to explore the factors influencing the 
effectiveness of behaviour change interventions to prevent excessive gestational weight 
gain. The authors reported limited effectiveness of interventions during pregnancy aimed 
to prevent excessive weight gain, despite the interventions being personalized and 
tailored on a case-by-case basis. Cited barriers of the interventions included fear of 
harming the unborn baby, general physical discomfort, discouragement to undertake 
physical tasks by people around them, and positive encouragement toward over eating 
(Campbell et al. 2011). These factors were found to lead to a general decline in physical 
activity and an increased risk of excessive gestational weight gain (Campbell et al., 
2011). General physical discomfort was often cited as a barrier to physical activity for My 
Clinic women, and one woman dropped out of NELIP because of it. It is also a 
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possibility, based on the high drop-out rates, that many participants were lacking the 
support network required for the intensive lifestyle modifications of NELIP. The majority 
of drop out participants cited the time commitment as the major barrier of the 
intervention, although it would be interesting to explore this further and discuss their 
individual support network (or lack thereof) in the future.  
There was one significant difference in the recruitment process for the NELIP 
intervention between the women studied in the laboratory setting and those in My Clinic. 
Intervention participants in the laboratory NELIP were self-referred and contacted study 
investigators after viewing study participation posters in midwifery/physician’s office 
and/or around the campus of Western University. On the basis of self-referrals, laboratory 
participants likely entered the study already in the contemplation stage of change. On the 
contrary, NELIP participants in the My Clinic setting were directly referred by their 
obstetrician and many remained in the pre-contemplation stage of change, which may 
have led to failure to comply with the intervention or the high dropout rates.  
Compared to the participants previously studied in the lab, the women at My Clinic were 
specifically obese class 2 and 3. My Clinic women also experienced various 
psychological issues such as depression and anxiety, which were frequently charted, 
perhaps related to the lack of perceived control associated with pregnancy, vulnerability, 
fear or past traumatic experiences (Campbell et al., 2011). Recording food intake and 
daily pedometer steps, essential to compliance and self-monitoring, may have repeatedly 
increased anxiety levels in this group of women, and anxiety was cited as a secondary 
reason for withdrawal from the intervention on more than one occasion. Women 
attending My Clinic were typically of lower socioeconomic status (as indicated from their 
medical charts), many were unemployed or receiving social assistance (with a few 
exceptions), which may differentiate this group of women from those studied in the lab. 
Unfortunately, the combination of behavioural, physical, psychological and 
sociodemographic factors (which were not measured in the present study) may have led 
to the 100% drop out rate in the more intensive intervention (NELIP) group. Future 
analyses should include all of these co-founding variables to assist in overcoming 
potential barriers to lifestyle change in obese class 2 and 3 women. 
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The more successful interventions of the study were those involving only one behaviour 
change; either the nutrition or exercise only groups. The nutrition group had a drop-out 
rate of 25%, while the exercise group had a drop-out rate of 40%. The exercise 
intervention was most efficacious in reducing GWG and keeping weight gain within the 
IOM guidelines. This may indicate that walking as the exercise modality, and as a single 
behaviour change, may be the best intervention for obese class 2 and 3 women. A 
walking intervention is an inexpensive method for increasing daily PA and can be easily 
implemented into daily clinical practice. A mild exercise program is important because it 
is an easier adjustment for obese women who were previously sedentary. Furthermore, 
obese individuals may have difficulties with nutrition, thereby making exercise in the 
form of walking or increasing daily step counts as a more realistic intervention.  
Haby et al. (2015) recently conducted a pilot study using prescribed physical activity, 
pedometers and walking poles to significantly reduce GWG in pregnant women with an 
average BMI of 33.1 kg/m2 in a midwifery setting. Food advice was given and counseling 
via a dietician was offered but the dietary program was not mandatory. Compliance 
characteristics were low in this study, with only 34% of women participating in the food 
discussion group and 50% using pedometers. Nonetheless, GWG was significantly lower 
in the exercise intervention group. 
Renault et al. (2014) had similar results to the current My Clinic study when assessing 
GWG in obese pregnant women using a physical activity intervention with or without 
dietary intervention. Renault et al. (2014) found no significant difference between the two 
interventions, concluding that the additive effect of the dietary program was not 
significant. Compliance was also an issue in the study as many participants did not follow 
the dietary advice.  
Although the nutrition intervention used a modified GDM meal plan combined with 
walking and was shown to prevent excessive GWG in the laboratory setting (Mottola et 
al. 2010), the nutrition component alone was not as effective as exercise in preventing 
excessive GWG. While exercise was a simple addition to their daily lives, the nutrition 
program was much more difficult to achieve. Non-compliance to the nutrition program 
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and under reporting of what they ate may be issues that resulted in the 14.6 ± 5.7 kg 
weight gain. Nevertheless, obese pregnant women might still benefit from regular visits 
to a dietician in a specialized obesity clinic who would be familiar with the nutrition 
recommendations for obese pregnant women.  
Research indicates maternal obesity is an independent risk factor for macrosomia 
(Artenisio et al., 1999). Class 2/3 obese women, specifically, have two times the odds of 
delivering an infant >4.0 kg compared to women of a normal BMI (Bellver et al., 2003). 
A 1.0 kg increment in infant birth weight was associated with a 50% increase in 
childhood overweight/obesity at 9-14 years of age (Gillman et al., 2003). However, 
literature has shown that a small decrease in maternal weight (one BMI unit) is enough to 
decrease the risk of macrosomia (Villamor and Cnattingius, 2006). Prevention of 
macrosomia is paramount in order to reduce the cycle of obesity for future generations.  
Along with reducing GWG, the exercise intervention significantly reduced macrosomia 
compared to My Clinic standard care. Both intervention groups along with My Clinic 
standard care prevented small birth weight babies. Babies born small are at a greater risk 
for obesity later in life, perhaps due to a period of catch-up growth, as well as an 
increased cardiovascular risk later in life (Mottola et al., 2010). Reducing macrosomia 
and small birth weight infants may perhaps be one step in preventing future childhood 
obesity by providing a healthy fetal environment and pregnancy lifestyle change for 
obese women. 
Despite being best practice, the full NELIP including both diet and physical activity was 
not a successful addition to My Clinic standard care. However, either component of the 
intervention as a single behaviour change (i.e. Nutrition-only or Exercise-only) was 
found to be beneficial in class 2/3 obese women at My Clinic. The exercise intervention 
was found to best limit GWG and keep weight gain within IOM guidelines, as well as 
significantly reduce the risk of macrosomia. Incorporating one behaviour change into 
their lifestyle, rather than two, seemed to be most efficacious for class 2/3 obese women 
at My Clinic.  
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5.3 Strengths/Limitations and Future Directions 
One strength of the current study was that it was designed to use an evidence-based best 
practice intervention program for overweight and obese pregnant women known as 
NELIP. NELIP in the laboratory setting had an impressive 80% success rate in 
preventing excessive weight gain in overweight and obese women during pregnancy. The 
exercise intervention and use of pedometers provided an inexpensive method for 
increasing daily physical activity that was easy to implement in the clinical setting and 
the delivery of the modified GDM diet with a specified meal plan was implemented by a 
dietitian associated with the specialized clinic. Theoretically, the delivery of the 
evidence-based intervention should have been complementary to the clinic setting. 
However, there were several limitations to the current study. Several women from the 
clinic were excluded because they were diagnosed with GDM early at the first visit 
screen for standard care. This exclusion criteria was necessary but also decreased the 
eligibility pool and lowered the number of women who agreed to participate in the study. 
In addition, a homogenous population was used and all women were Caucasian, reducing 
the risk of bias but also lowering external validity. There was a very wide range of weight 
gain, indicating that participants likely did not adhere to the dietary and/or exercise 
advice. The probability of underreporting of food intake and over reporting of pedometer 
steps or frequency of exercise may have been high. Pre-pregnancy weight was self-
reported, which may be slightly different than if it were directly measured. In addition, 
the final sample size in the current study was small. The 2011 perinatal database was 
used as a proxy for the women referred to My Clinic as the 2012/2013 databases were not 
available at the time of data collection. Unfortunately, the 2011 perinatal database did not 
adhere to the CDA guideline updates (2013), and it remains unknown if some of the 
women in the perinatal database would have been diagnosed with GDM according to the 
updated current criteria.  
Another possible limitation of the current study was the lack of self-monitoring that 
occurred in both the nutrition and exercise groups. The Nutrition-only group self-
monitored food intake, however they did not record step counts so it remains unknown 
how active these women were. In addition, the Exercise-only group completed the 
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exercise log with pedometer steps but did not monitor nutrition, although both groups had 
access to My Clinic standard care with nutrition and exercise advice. To avoid burdening 
the women they did not have to self-monitor both behaviours, as these results would have 
been seen in the full NELIP group. Unfortunately, 100% of the women receiving the full 
NELIP dropped out so the results of self-monitoring two behaviours remain unknown. 
Future direction may include additional measurement of nutrition and exercise behaviour 
without using self-monitoring of the behaviour not being changed. For example, in the 
Exercise-only group, perhaps a food frequency questionnaire could be used at the 
beginning and at the end of the study to capture change in nutrition behaviour and an 
exercise questionnaire such as the Kaiser questionnaire validated for pregnant women 
(Schmidt et al., 2006) could be used to capture change in exercise behaviour pre and post 
intervention in all groups. In addition, future studies should be based on theories of 
behaviour change specifically designed for obese class 2 and 3 pregnant women.  
Many questions remain unanswered as to how to best approach multiple behaviour 
change. Research is inconclusive and both sequential and simultaneous behaviour change 
have shown success depending on the intervention and individual (Vandelanotte et al., 
2008). Perhaps participants would benefit from a tailored, individualized intervention 
where they are able to choose how they wish to integrate the multiple behaviour changes 
into their lifestyle (either sequentially or simultaneously). 
Pregnant women attending My Clinic may have mental health issues including depression 
and anxiety (personal observation). An integrative team approach to obstetrical care 
should be continued at My Clinic, however, additional support of a social worker, 
psychologist and/or psychiatrist could be beneficial in the antenatal treatment plan to 
assist these women with the unique barriers they face related to class 2 and 3 obesity. 
Literature reveals that individuals tend to engage in activities in which they believe they 
can succeed – without confidence in their success one will not be successful (Savage et 
al., 2014). Furthermore, research suggests individuals must perceive the benefits of 
physical activity and healthy nutrition to ultimately change their lifestyles and be 
compliant to an intervention (McGiveron et al., 2014). Unrealistic expectations regarding 
weight management in obese individuals can often lead to disappointment and non-
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adherence (Canadian Obesity Network, 2011). Future intervention studies at My Clinic 
may benefit from patient education workshops focusing on setting appropriate GWG 
goals, with the emphasis on prevention of excessive weight gain, and problem solving 
skills to overcome their unique barriers and time management skills. Workshops 
previously provided by My Clinic in the group setting were lacking in attendance. 
Perhaps this group of obese women may respond better to anonymity and may benefit 
from one-on-one goal setting and time management counseling sessions in the future.  
In a randomized trial, Harrison et al. (2014) found that regular self-weighing combined 
with a self-management intervention optimized pregnancy weight gain compared to 
control participants. Intervention participants in the trial were encouraged to plot and 
track their weekly GWG on a chart. While My Clinic patients were weighed in the clinic 
at all appointments, self-weighing was not necessarily encouraged. It remains unknown if 
self-weighing would be efficacious for the My Clinic population and result in improved 
self-management of obesity.  
Evidence suggests pregnancy presents a new maternal awareness of the ability to impact 
infant health (Phelan et al., 2014). Pregnant women are often highly motivated to make 
healthy lifestyle changes and many argue that pregnancy is an ideal time to provide an 
intervention to benefit both mother and infant (Artal et al., 2007). On the contrary, 
research indicates that many women also feel that pregnancy is an opportunity to not 
worry about their weight, which leads to increased caloric intake (Clark and Ogden, 
1999). Both of these scenarios were indicated (personal observation) in the participants 
from My Clinic and should be explored further in an attempt to find common themes.  
Despite the challenges related to integrating NELIP in the My Clinic setting, the unique 
intervention program should be continued for class 2/3 obese pregnant women at risk for 
excessive weight gain and macrosomic babies. The non-pregnant and pregnant literature 
concludes the best weight control strategies involve a combination of physical activity 
and nutritional management, with the possible addition of behavioural strategies (Phelan 
et al., 2011). However, obese class 2 and 3 pregnant women may have difficulty with two 
behaviour changes simultaneously. As a result, obese women may find one intensive 
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lifestyle change easier to achieve. These pilot results should be further pursued to explore 
the efficacy of lifestyle interventions for obese class 2 and 3 pregnant women in the 
clinical setting.  
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Appendix A2 Weight & Health History Questionnaire 
 
 1 
Unique Identifier: ___________________________ Today’s date: _______________________ 
 
Weight & Health History Questionnaire 
 
Please answer the following questions to the best of your ability.   
All of the answers gained through this survey will be held in the strictest of confidence. 
 
 
Section A – Background Information: 
 
1) What is your date of birth? _____________________ (month, day, year) 
 
2) What is your ethnic background? 
 Caucasian  Hispanic   Aboriginal  (please circle:   First Nations,     Métis,     Inuit )  
 Asian    African American  Other, please specify _________________ 
 
3) What is your height? ____________ feet ____________ inches, OR ____________ centimeters 
 
4) What education level did you complete? Please check all that apply. 
 Elementary school   High school    College  
 University  (please circle: certificate,  bachelor,   master,  doctorate)  
 Other, please specify________________ 
 
 
Section B – Current Pregnancy: 
 
5) What has been your usual adult body weight?  ____________ pounds, OR ____________ kilograms 
 
6) How much weight did  you plan to gain during this pregnancy?  
____________ pounds, OR ____________ kilograms 
 
7) How much weight  did you gain during this pregnancy? 
 
____________ pounds, OR ____________ kilograms 
 
8) What was your body weight one year before this pregnancy? 
____________ pounds, OR ____________ kilograms 
 
9) What was your body weight immediately before this pregnancy?  
____________ pounds, OR ____________ kilograms 
 
 
 
10) Were you actively trying to reduce your body weight in the year before this pregnancy?  
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 No  If Yes, how much weight did you lose? ____________ pounds, OR ____________ kilograms 
11) What have your eating habits been like in the year before this pregnancy? Check all that apply. 
 one meal per day, specify when ____________________________________ 
 two meals per day, specify when _____________________________________ 
 three meals per day 
 snack(s) every day, specify when ______________________________________________ 
 Special diet, please specify name ___________________________________________________________ 
 Trying to follow Canada’s Food Guide to Healthy Eating 
 Other nutrition plan, please specify 
__________________________________________________________  
 
12) What has your pattern of physical activity been like in the year before this pregnancy?  
Type of  
Physical Activity 
Frequency 
 
Average Duration  
of your exercise 
sessions 
Intensity 
(low, medium, high) 
Location 
(home, outdoors, 
gym, etc.) 
 _________  
time(s) per week 
_________ minutes   
 _________  
time(s) per week 
_________ minutes   
 _________  
time(s) per week 
_________ minutes   
 _________  
time(s) per week 
_________ minutes   
 
 
13) How would you qualify your current level of stress on most days?  
 No stress. 
 Low stress level. 
 Moderate stress level. 
 High stress level.  You perceive it as a problem. 
 
14)  Was this your first pregnancy?  
 No   Yes 
 
 
 
Section C – Previous Pregnancies: 
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15)  Please fill the following chart.  
 Age  
you were 
Body weight you were 
immediately before 
pregnancy 
Weight you gained 
during pregnancy 
Weight retained after 
pregnancy 
(never really lost) 
1st pregnancy  _________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
2nd pregnancy  _________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
3rd pregnancy  _________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
4th pregnancy  _________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
5th pregnancy  _________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
_________pounds,  
OR __________kg 
 
Other pregnancies: ____________________________________________________________________________ 
 
16)  For each pregnancy, what were the gestational age, gender and approximate birth weight and length?   
 Gestational Age 
 
Gender Birth weight Birth Length  
1st baby _________ weeks  _________pounds 
___________ounces,  
OR __________kg 
_________inches,  
OR __________cm 
2nd baby _________ weeks  _________pounds 
___________ounces,  
OR __________kg 
_________inches,  
OR __________cm 
3rd baby _________ weeks  _________pounds 
___________ounces, 
OR __________kg 
_________inches,  
OR __________cm 
4th baby _________ weeks  _________pounds 
___________ounces, 
OR __________kg 
_________inches,  
OR __________cm 
5th baby _________ weeks  _________pounds 
___________ounces, 
OR __________kg 
_________inches,  
OR __________cm 
 
Other babies: _______________________________________________________________________________ 
17)  Please indicate how you fed your baby(ies).   
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 Breastfeeding 
started 
Duration of 
breastfeeding only 
Age breastfeeding 
was stopped 
Age at introduction 
of first solid foods  
1st baby ____ Yes,  ____ No  _________ months _________ months _________ months 
2nd baby ____ Yes,  ____ No _________ months _________ months _________ months 
3rd baby ____ Yes,  ____ No _________ months _________ months _________ months 
4th baby ____ Yes,  ____ No _________ months _________ months _________ months 
5th baby ____ Yes,  ____ No _________ months _________ months _________ months 
 
Other babies: ____________________________________________________________________ 
 
Section D – Weight History: 
 
18) What was your birth weight?  ____________ pounds _____________ ounces, OR ____________ kilograms 
 
19) What was your birth length?  ____________ inches, OR ____________ centimeters 
 
20) How has your body weight been since you were 19 years of age? 
 stable  (always about the same weight, only changing by a couple of pounds when I am not pregnant),  
please skip to question 28  
 unstable and progressively increasing    
 unstable, because it has been going up and down often 
 unstable, I feel I have been gaining weight with each pregnancy  
 Other, please describe ______________________________________________________________    
    
21) By how many pounds or kilograms does your body weight tend to fluctuate (or change) per year? 
In average about ____________ pounds, OR ____________ kilograms per year. 
 
22) What do you think causes your body weight to be unstable?  Please explain. 
_______________________________________________________________________________________
_______________________________________________________________________________________ 
_______________________________________________________________________________________ 
 
23)  Have you ever actively tried to lose weight?  
 Yes   If  No, please skip to question 28 
 
24)  How old were you when you first actively tried to lose weight? ____________________________________ 
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25)  What method did you use when you first actively tried to lose weight? 
__________________________________________________________________________________________ 
26) Since you were 19 years old, how many times have you been actively trying to lose weight and at what 
ages?  Please explain.  
___________________________________________________________________________________________
___________________________________________________________________________________________ 
 
27) List all the methods you have tried to lose weight. 
 Vitamin/mineral supplement, please specify __________________________________________________ 
  
 Dietary changes or special diets, please specify 
________________________________________________ 
_____________________________________________________________________________________ 
 Physical activity, please specify ______________________________________________________
 ______ 
____________________________________________________________________________________ 
 Pills or herbal products, please describe _____________________________________________________  
  
 ____________________________________________________________________________________ 
 Prescribed medication, please describe ______________________________________________________  
  
 ____________________________________________________________________________________ 
 Surgery, please describe _________________________________________________________________  
 ____________________________________________________________________________________ 
 Meetings with a health care professional(s), please indicate which professional(s) ____________________ 
 ____________________________________________________________________________________ 
 Other, please describe ___________________________________________________________________  
 ____________________________________________________________________________________ 
 
28) What was the maximum weight you ever lost, how long did it take you to lose that weight and what method 
did you use?   
I lost ________ pounds, OR _________ kilograms in ___________ months, using the following method 
____________________________________________________________________________________ 
29) Have you ever consulted a physician about weight issues or for weight management purposes?  
 No 
 No, but I would like to. 
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 Yes, and it was helpful.  Explain ____________________________________________________ 
 Yes, but it was not helpful.  Explain _________________________________________________ 
 
30) Have you ever consulted a registered dietitian about weight issues or for weight management purposes?  
 No 
 No, but I would like to. 
 Yes, and it was helpful.  Explain ____________________________________________________ 
 Yes, but it was not helpful.  Explain _________________________________________________ 
 
31) If you choose a method to lose weight in the future, what will you be looking for as important characteristics? 
Check the three (3)  most important factors for you. 
 Group meetings     Individual support 
 Short-term results     Long-term results 
 Minimum time commitment    Follow-up support  
 Education      Learning healthier lifestyle choices   
 Expert advice by registered dietitian   Expert advice by physician 
 Expert advice by exercise physiologist   Cost       
 Safety      Help with stress management  
 Other, please specify _________________________________________________________ 
 
Section E – About Your Health: 
 
32) Have you ever been diagnosed with: 
Type 1 Diabetes Mellitus   Yes   No 
Type 2 Diabetes Mellitus   Yes   No 
Gestational Diabetes Mellitus   Yes   No 
Pre-diabetes      Yes   No 
Gestational hypertension   Yes   No 
Polycystic Ovarian Syndrome   Yes   No 
 
33) Do you currently, or have you ever  taken medication for diabetes or pre-diabetes: 
 No  If Yes, please describe 
__________________________________________________________  
 
Section F – About Your Family: 
 
34) How many siblings do you have?   
_________ Sister(s)    _________ Brother(s)   I do not know 
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35) How many of your siblings are overweight or obese?  
_________ Sister(s)  _________ Brother(s)   I do not know 
36) Is there a history of overweight or obesity in the rest of your immediate family?   (Check all that apply) 
 Your mother   Your father 
 Grandmother on your mother’s side  Grandfather on your mother’s side 
 Grandmother on your father’s side  Grandfather on your father’s side 
 None   I do not know   Other(s), please 
specify:______________________________  
 
37) How many of your siblings have diabetes?  
_________ Sister(s)  _________ Brother(s)   I do not know 
 
38) Is there a history of diabetes in the rest of your immediate family?    (Check all that apply) 
 Your  mother  Your father 
 Grandmother on your mother’s side  Grandfather on your mother’s side 
 Grandmother on your father’s side   Grandfather on your father’s side 
 None   I do not know   Other(s), please 
specify:______________________________  
 
39) What is the height and weight of the father of your child to be? 
Height  ___________ feet ___________ inches, OR _________________ centimeters 
Weight ___________ pounds, OR _______________ kilograms 
 
40) What is the ethnic background of the father of your child to be? 
 Caucasian  Hispanic   Aboriginal  (please circle:   First Nations,     Métis,     Inuit )  
 Asian    African American  Other, please specify _________________ 
 
41) How many siblings does the father of your child to be have?   
_________ Sister(s)    _________ Brother(s)  I do not know 
 
42) How many of the father’s siblings are overweight or obese?  
_________ Sister(s)  _________ Brother(s)   I do not know 
 
43) How many of the father’s siblings have diabetes?  
_________ Sister(s)  _________ Brother(s)   I do not know 
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Appendix A3 PARmed-X for Pregnancy 
 
1
Physical Activity Readiness  
Medical Examination for  
Pregnancy
*NOTE:  PREGNANT WOMEN ARE STRONGLY ADVISED NOT TO SMOKE 
OR CONSUME ALCOHOL DURING PREGNANCY AND DURING LACTATION. 
+HDOWK\ZRPHQZLWKXQFRPSOLFDWHGSUHJQDQFLHVFDQ LQWHJUDWHSK\VLFDODFWLYLW\ LQWR WKHLUGDLO\ OLYLQJDQGFDQSDUWLFLSDWHZLWKRXWVLJQLÀFDQW ULVNVHLWKHU WR
WKHPVHOYHVRUWRWKHLUXQERUQFKLOG3RVWXODWHGEHQHÀWVRIVXFKSURJUDPVLQFOXGHLPSURYHGDHURELFDQGPXVFXODUÀWQHVVSURPRWLRQRIDSSURSULDWHZHLJKW
JDLQDQGIDFLOLWDWLRQRIODERXU5HJXODUH[HUFLVHPD\DOVRKHOSWRSUHYHQWJHVWDWLRQDOJOXFRVHLQWROHUDQFHDQGSUHJQDQF\LQGXFHGK\SHUWHQVLRQ
7KHVDIHW\RISUHQDWDOH[HUFLVHSURJUDPVGHSHQGVRQDQDGHTXDWHOHYHORIPDWHUQDOIHWDOSK\VLRORJLFDOUHVHUYH3$5PHG;IRU35(*1$1&<LVDFRQYHQLHQW
FKHFNOLVWDQGSUHVFULSWLRQIRUXVHE\KHDOWKFDUHSURYLGHUVWRHYDOXDWHSUHJQDQWSDWLHQWVZKRZDQWWRHQWHUDSUHQDWDOÀWQHVVSURJUDPDQGIRURQJRLQJPHGLFDO
VXUYHLOODQFHRIH[HUFLVLQJSUHJQDQWSDWLHQWV
,QVWUXFWLRQVIRUXVHRIWKHSDJH3$5PHG;IRU35(*1$1&<DUHWKHIROORZLQJ
 7KHSDWLHQWVKRXOGÀOORXWWKHVHFWLRQRQ3$7,(17,1)250$7,21DQGWKH35((;(5&,6(+($/7+&+(&./,673$57DQGRQSDQGJLYH
WKHIRUPWRWKHKHDOWKFDUHSURYLGHUPRQLWRULQJKHUSUHJQDQF\
 7KHKHDOWKFDUHSURYLGHUVKRXOGFKHFNWKHLQIRUPDWLRQSURYLGHGE\WKHSDWLHQWIRUDFFXUDF\DQGÀOORXW6(&7,21&RQ&2175$,1',&$7,216SEDVHG
RQFXUUHQWPHGLFDOLQIRUPDWLRQ
 ,IQRH[HUFLVHFRQWUDLQGLFDWLRQVH[LVWWKH+($/7+(9$/8$7,21)250SVKRXOGEHFRPSOHWHGVLJQHGE\WKHKHDOWKFDUHSURYLGHUDQGJLYHQE\WKH
SDWLHQWWRKHUSUHQDWDOÀWQHVVSURIHVVLRQDO
,QDGGLWLRQWRSUXGHQWPHGLFDOFDUHSDUWLFLSDWLRQLQDSSURSULDWHW\SHVLQWHQVLWLHVDQGDPRXQWVRIH[HUFLVHLVUHFRPPHQGHGWRLQFUHDVHWKHOLNHOLKRRGRIDEHQHÀFLDO
SUHJQDQF\RXWFRPH3$5PHG;IRU35(*1$1&<SURYLGHVUHFRPPHQGDWLRQVIRULQGLYLGXDOL]HGH[HUFLVHSUHVFULSWLRQSDQGSURJUDPVDIHW\S
PARmed-X for PREGNANCY is a guideline for health screening  
SULRUWRSDUWLFLSDWLRQLQDSUHQDWDOÀWQHVVFODVVRURWKHUH[HUFLVH
127( 6HFWLRQV$DQG%VKRXOGEHFRPSOHWHGE\WKHSDWLHQWEHIRUHWKHDSSRLQWPHQWZLWKWKHKHDOWKFDUHSURYLGHU.
A PATIENT INFORMATION
1$0( ____________________________________________________________________________________________________________________________________
$''5(66 _________________________________________________________________________________________________________________________________
7(/(3+21( ______________________________ %,57+'$7( ______________________+($/7+,1685$1&(1R __________________________________________
1$0(2) 35(1$7$/),71(66
35(1$7$/),71(66352)(66,21$/ __________________________________________352)(66,21$/·63+21(180%(5 _________________________________  
B PRE-EXERCISE HEALTH CHECKLIST
PART 1:  GENERAL HEALTH STATUS
,QWKHSDVWKDYH\RXH[SHULHQFHGFKHFN<(6RU12  
 <(6 12
 0LVFDUULDJHLQDQHDUOLHUSUHJQDF\" R R
 2WKHUSUHJQDQF\FRPSOLFDWLRQV" R R 
 ,KDYHFRPSOHWHGD3$54ZLWKLQWKHODVWGD\V R R 
,I\RXDQVZHUHG<(6WRTXHVWLRQRUSOHDVHH[SODLQ
__________________________________________________________
1XPEHURISUHYLRXVSUHJQDQFLHV"  _______   
PART 2:  STATUS OF CURRENT PREGNANCY
'XH'DWH ________________________________________________
'XULQJWKLVSUHJQDQF\KDYH\RXH[SHULHQFHG
 <(6 12
 0DUNHGIDWLJXH" R R 
 %OHHGLQJIURPWKHYDJLQD´VSRWWLQJµ" R R 
 8QH[SODLQHGIDLQWQHVVRUGL]]LQHVV" R R 
 8QH[SODLQHGDEGRPLQDOSDLQ" R R 
 6XGGHQVZHOOLQJRIDQNOHVKDQGVRUIDFH" R R 
 3HUVLVWHQWKHDGDFKHVRUSUREOHPVZLWKKHDGDFKHV" R R 
 6ZHOOLQJSDLQRUUHGQHVVLQWKHFDOIRIRQHOHJ" R R 
 $EVHQFHRIIHWDOPRYHPHQWDIWHUthPRQWK" R R 
 )DLOXUHWRJDLQZHLJKWDIWHUthPRQWK" R R 
,I\RXDQVZHUHG<(6WRDQ\RIWKHDERYHTXHVWLRQVSOHDVHH[SODLQ
_________________________________________________________
PART 3:  ACTIVITY HABITS DURING THE PAST MONTH
 /LVWRQO\UHJXODUÀWQHVVUHFUHDWLRQDODFWLYLWLHV
  ____________________________________________________
  ____________________________________________________
 ,17(16,7< )5(48(1&<  7,0( 
  WLPHVZHHN PLQXWHVGD\
   +   +
 Heavy  ___   ___   ___   ___   ___   ___  
 0HGLXP  ___   ___   ___   ___   ___   ___  
 /LJKW  ___   ___   ___   ___   ___   ___
 'RHV\RXUUHJXODURFFXSDWLRQMREKRPHDFWLYLW\LQYROYH
 <(6 12
 +HDY\/LIWLQJ" R R 
 )UHTXHQWZDONLQJVWDLUFOLPELQJ" R R 
 2FFDVLRQDOZDONLQJ!RQFHKU" R R 
 3URORQJHGVWDQGLQJ" R R 
 0DLQO\VLWWLQJ" R R 
 1RUPDOGDLO\DFWLYLW\" R R
 'R\RXFXUUHQWO\VPRNHWREDFFR" R R
 'R\RXFRQVXPHDOFRKRO" R R
PART 4:  PHYSICAL ACTIVITY INTENTIONS
:KDWSK\VLFDODFWLYLW\GR\RXLQWHQGWRGR"
_________________________________________________________
IVWKLVDFKDQJHIURPZKDW\RXFXUUHQWO\GR" R <(6 R 12
&DQDGLDQ6RFLHW\IRU([HUFLVH3K\VLRORJ\
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Prescription for Aerobic Activity
RATE OF PROGRESSION:  The best time to progress is during the second 
WULPHVWHUVLQFHULVNVDQGGLVFRPIRUWVRISUHJQDQF\DUH ORZHVWDW WKDW WLPH
$HURELFH[HUFLVHVKRXOGEHLQFUHDVHGJUDGXDOO\GXULQJWKHVHFRQGWULPHVWHU
IURPDPLQLPXPRIPLQXWHVSHUVHVVLRQWLPHVSHUZHHNDWWKHDSSURSULDWH
WDUJHWKHDUWUDWHRU53(WRDPD[LPXPRIDSSUR[LPDWHO\PLQXWHVSHUVHVVLRQ
WLPHVSHUZHHNDWWKHDSSURSULDWHWDUJHWKHDUWUDWHRU53(
WARM-UP/COOL-DOWN: $HURELFDFWLYLW\VKRXOGEHSUHFHGHGE\DEULHI
PLQZDUPXSDQGIROORZHGE\DVKRUWPLQFRROGRZQ/RZ
LQWHQVLW\FDOHVWKHQLFVVWUHWFKLQJDQGUHOD[DWLRQH[HUFLVHVVKRXOGEHLQFOXGHG
LQWKHZDUPXSFRROGRZQ
PRESCRIPTION/MONITORING OF INTENSITY:  The best way to prescribe 
DQGPRQLWRUH[HUFLVHLVE\FRPELQLQJWKHKHDUWUDWHDQGUDWLQJRISHUFHLYHG
H[HUWLRQ53(PHWKRGV
“TALK TEST” $ÀQDOFKHFNWRDYRLGRYHUH[HUWLRQLVWRXVHWKH´ WDONWHVWµ7KH
H[HUFLVHLQWHQVLW\LVH[FHVVLYHLI\RXFDQQRWFDUU\RQDYHUEDOFRQYHUVDWLRQ
ZKLOHH[HUFLVLQJ
3+<6,&$/$&7,9,7<5(&200(1'$7,21 ! 5HFRPPHQGHG$SSURYHG ! &RQWUDLQGLFDWHG
7KHRULJLQDO3$5PHG;IRU35(*1$1&<ZDVGHYHORSHGE\/$:ROIH3K'4XHHQ·V8QLYHUVLW\DQGXSGDWHGE\'U0)0RWWROD3K'8QLYHUVLW\RI:HVWHUQ
2QWDULR
 No changes permitted. Translation and reproduction in its entirety is encouraged. 
'LVSRQLEOHHQIUDQoDLVVRXVOHWLWUH©([DPLQDWLRQPHGLFDOHVXUO·DSWLWXGHjO·DFWLYLWpSK\VLTXHSRXUOHVIHPPHVHQFHLQWHV;$$3SRXUOHVIHPPHVHQFHLQWHVª
$GGLWLRQDOFRSLHVRIWKH3$5PHG;IRU35(*1$1&<FDQEHGRZQORDGHGIURP 
&DQDGLDQ6RFLHW\IRU([HUFLVH3K\VLRORJ\
ZZZFVHSFDIRUPV
INTENSITY
([HUFLVHZLWKLQ 
an appropriate  
53(UDQJH 
DQGRUWDUJHW 
heart rate  
]RQH
TYPE
1RQZHLJKWEHDULQJ 
RUORZLPSDFWHQGXUDQFH
H[HUFLVHXVLQJODUJH
PXVFOHJURXSVHJ
ZDONLQJVWDWLRQDU\
F\FOLQJVZLPPLQJ
DTXDWLFH[HUFLVHVORZ 
LPSDFWDHURELFV
I
FREQUENCY
%HJLQDWWLPHV 
SHUZHHNDQG 
progress to  
IRXUWLPHV 
SHUZHHN
F
TIME
$WWHPSW 
PLQXWHVHYHQ 
LILWPHDQV 
reducing the 
intensity.  
5HVWLQWHUYDOV 
PD\EHKHOSIXO
T T
RATING OF  
PERCEIVED  
EXERTION (RPE)
&KHFN WKH DFFXUDF\ RI
your heart rate target 
]RQH E\ FRPSDULQJ LW
WR WKH VFDOH EHORZ  $
UDQJH RI DERXW 
VRPHZKDW KDUG LV
DSSURSULDWH IRU PRVW
pregnant women.
 6 
  9HU\YHU\OLJKW 
 8 
  6RPHZKDWOLJKW 
 
  )DLUO\OLJKW 
 
 6RPHZKDWKDUG 
 
 15 Hard 
 16 
 9HU\KDUG 
 18 
 9HU\YHU\KDUG 

C CONTRAINDICATIONS TO EXERCISE:  to be completed by your health care provider
Absolute Contraindications
'RHVWKHSDWLHQWKDYH
 <(6 12
 5XSWXUHGPHPEUDQHVSUHPDWXUHODERXU" ! !
 3HUVLVWHQWVHFRQGRUWKLUGWULPHVWHU 
EOHHGLQJSODFHQWDSUHYLD" ! !
 3UHJQDQF\LQGXFHGK\SHUWHQVLRQRUSUHHFODPSVLD" ! !
 ,QFRPSHWHQWFHUYL[" ! !
 (YLGHQFHRILQWUDXWHULQHJURZWKUHVWULFWLRQ" ! !
 +LJKRUGHUSUHJQDQF\HJWULSOHWV" ! !
 8QFRQWUROOHG7\SH,GLDEHWHVK\SHUWHQVLRQRU 
WK\URLGGLVHDVHRWKHUVHULRXVFDUGLRYDVFXODU 
UHVSLUDWRU\RUV\VWHPLFGLVRUGHU" ! !
Relative Contraindications
'RHVWKHSDWLHQWKDYH
 <(6 12
 +LVWRU\RIVSRQWDQHRXVDERUWLRQRUSUHPDWXUHODERXU 
LQSUHYLRXVSUHJQDQFLHV" ! !
 0LOGPRGHUDWHFDUGLRYDVFXODURUUHVSLUDWRU\GLVHDVH 
HJFKURQLFK\SHUWHQVLRQDVWKPD" ! !
 $QHPLDRULURQGHÀFLHQF\"+EJ/" ! !
 0DOQXWULWLRQRUHDWLQJGLVRUGHUDQRUH[LDEXOLPLD" ! !
 7ZLQSUHJQDQF\DIWHUWKZHHN" ! !
 2WKHUVLJQLÀFDQWPHGLFDOFRQGLWLRQ" ! !
 3OHDVHVSHFLI\ ___________________________________________
NOTE: 5LVNPD\H[FHHGEHQHÀWVRIUHJXODUSK\VLFDODFWLYLW\7KHGHFLVLRQWR 
EHSK\VLFDOO\DFWLYHRUQRWVKRXOGEHPDGHZLWKTXDOLÀHGPHGLFDODGYLFH 
PHYSICAL ACTIVITY READINESS 
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HEART RATE RANGES FOR PREGNANT 
WOMEN 
0$7(51$/
$*(
),71(66
/(9(/RU%0,
+($575$7(
5$1*(
EHDWVPLQXWH
/HVVWKDQ

 
² /RZ
$FWLYH
)LW
%0,!NJP




² /RZ
$FWLYH
)LW
%0,!NJP




7DUJHW+5UDQJHVZHUHGHULYHGIURPSHDN
H[HUFLVHWHVWVLQPHGLFDOO\SUHVFUHHQHGORZULVN
ZRPHQZKRZHUHSUHJQDQW0RWWRODHWDO
'DYHQSRUWHWDO
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PRECAUTIONS FOR MUSCULAR CONDITIONING DURING PREGNANCY
 LQWKHVXSLQHSRVLWLRQO\LQJRQWKHEDFNWKHHQODUJHGXWHUXV
PD\HLWKHUGHFUHDVHWKHÁRZRIEORRGUHWXUQLQJIURPWKHORZHU
KDOIRIWKHERG\DVLWSUHVVHVRQDPDMRUYHLQLQIHULRUYHQDFDYD
RULWPD\GHFUHDVHÁRZWRDPDMRUDUWHU\DEGRPLQDODRUWD
 OLJDPHQWVEHFRPHUHOD[HGGXHWRLQFUHDVLQJKRUPRQHOHYHOV
 MRLQWVPD\EHSURQHWRLQMXU\
 SUHVHQFHRIDULSSOLQJEXOJLQJRIFRQQHFWLYHWLVVXHDORQJWKH
PLGOLQHRIWKHSUHJQDQWDEGRPHQGLDVWDVLVUHFWLPD\EHVHHQ
GXULQJDEGRPLQDOH[HUFLVH
 LQFUHDVLQJZHLJKWRIHQODUJHGEUHDVWVDQGXWHUXVPD\FDXVHD
IRUZDUGVKLIWLQWKHFHQWUHRIJUDYLW\DQGPD\LQFUHDVHWKHDUFKLQ
WKHORZHUEDFN
 WKLVPD\DOVRFDXVHVKRXOGHUVWRVOXPSIRUZDUG
())(&762)35(*1$1&<9$5,$%/(
%RG\3RVLWLRQ
-RLQW/D[LW\
$EGRPLQDO0XVFOHV
 
Posture
Precautions
IRU 
5HVLVWDQFH([HUFLVH
 SDVWPRQWKVRIJHVWDWLRQH[HUFLVHVQRUPDOO\GRQHLQWKH
supine position should be altered
 VXFKH[HUFLVHVVKRXOGEHGRQHVLGHO\LQJRUVWDQGLQJ
 DYRLGUDSLGFKDQJHVLQGLUHFWLRQDQGERXQFLQJGXULQJH[HUFLVHV
 VWUHWFKLQJVKRXOGEHSHUIRUPHGZLWKFRQWUROOHGPRYHPHQWV
 DEGRPLQDOH[HUFLVHVDUHQRWUHFRPPHQGHGLIGLDVWDVLVUHFWL
develops 
• emphasis on correct posture and neutral pelvic alignment.  
1HXWUDOSHOYLFDOLJQPHQWLVIRXQGE\EHQGLQJWKHNQHHV
IHHWVKRXOGHUZLGWKDSDUWDQGDOLJQLQJWKHSHOYLVEHWZHHQ
accentuated lordosis and the posterior pelvic tilt position.  
 
+($/7+&$5(3529,'(5·6&200(176
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
PARmed-X for Pregnancy - Health Evaluation Form
WREHFRPSOHWHGDQGJLYHQWRWKHSUHQDWDOÀWQHVVSURIHVVLRQDO 
DIWHUREWDLQLQJPHGLFDOFOHDUDQFHWRH[HUFLVH
, _____________________________________ 3/($6(35,17SDWLHQW·VQDPHKDYHGLVFXVVHGP\SODQVWRSDUWLFLSDWHLQSK\VLFDO
activityGXULQJP\FXUUHQWSUHJQDQF\ZLWKP\KHDOWKFDUHSURYLGHUDQG,KDYHREWDLQHGKLVKHUDSSURYDOWREHJLQSDUWLFLSDWLRQ
6LJQHG ___________________________________________  'DWH ____________________________________________
 SDWLHQW·VVLJQDWXUH
1DPHRIKHDOWKFDUHSURYLGHU _________________________________
$GGUHVV __________________________________________________
__________________________________________________________
7HOHSKRQH _________________________________________________
 KHDOWKFDUHSURYLGHU·VVLJQDWXUH
:$50836	&22/'2:1
5DQJHRI0RWLRQQHFNVKRXO
GHUJLUGOHEDFNDUPVKLSV
NQHHVDQNOHVHWF
6WDWLF6WUHWFKLQJDOOPDMRU
muscle groups 
(DO NOT OVER STRETCH!)
EXAMPLES OF MUSCULAR STRENGTHENING EXERCISES
 CATEGORY PURPOSE EXAMPLE
8SSHUEDFN 3URPRWLRQRIJRRGSRVWXUH 6KRXOGHUVKUXJVVKRXOGHUEODGHSLQFK
/RZHUEDFN 3URPRWLRQRIJRRGSRVWXUH 0RGLÀHGVWDQGLQJRSSRVLWHOHJ	DUPOLIWV
$EGRPHQ 3URPRWLRQRIJRRGSRVWXUH $EGRPLQDOWLJKWHQLQJDEGRPLQDO 
 SUHYHQWORZEDFNSDLQSUHYHQW FXUOXSVKHDGUDLVHVO\LQJRQVLGHRUVWDQGLQJSRVLWLRQ 
 GLDVWDVLVUHFWLVWUHQJWKHQPXVFOHVRIODERXU
3HOYLFÁRRU 3URPRWLRQRIJRRGEODGGHUFRQWURO ´:DYHµ´HOHYDWRUµ 
´.HJHOVµ SUHYHQWLRQRIXULQDU\LQFRQWLQHQFH
8SSHUERG\ ,PSURYHPXVFXODUVXSSRUWIRUEUHDVWV 6KRXOGHUURWDWLRQVPRGLÀHGSXVKXSVDJDLQVWDZDOO
%XWWRFNV )DFLOLWDWLRQRIZHLJKWEHDULQJSUHYHQWLRQ %XWWRFNVVTXHH]HVWDQGLQJOHJOLIWVKHHOUDLVHV 
ORZHUOLPEV RIYDULFRVHYHLQV
It is important to condition all 
major muscle groups during 
both prenatal and postnatal 
periods.
Prescription for Muscular Conditioning
 HPSKDVLVPXVWEHSODFHGRQFRQWLQXRXVEUHDWKLQJWKURXJKRXWH[HUFLVH
 H[KDOHRQH[HUWLRQLQKDOHRQUHOD[DWLRQXVLQJKLJKUHSHWLWLRQVDQGORZZHLJKWV
 9DOVDOYD0DQRHYUHKROGLQJEUHDWKZKLOHZRUNLQJDJDLQVWDUHVLVWDQFHFDXVHVDFKDQJHLQEORRGSUHVVXUHDQGWKHUHIRUH 
should be avoided
 DYRLGH[HUFLVHLQVXSLQHSRVLWLRQSDVWPRQWKVJHVWDWLRQ

PHYSICAL ACTIVITY READINESS 
MEDICAL EXAMINATIONPARmed-X for PREGNANCY
81 
 
 
 
 
Physical Activity Readiness  
Medical Examination for  
Pregnancy 

SAFETY CONSIDERATIONS
X $YRLGH[HUFLVHLQZDUPKXPLGHQYLURQPHQWVHVSHFLDOO\GXULQJ
the 1st trimester
X $YRLGLVRPHWULFH[HUFLVHRUVWUDLQLQJZKLOHKROGLQJ\RXUEUHDWK
X 0DLQWDLQDGHTXDWHQXWULWLRQDQGK\GUDWLRQ³GULQNOLTXLGV
EHIRUHDQGDIWHUH[HUFLVH
X $YRLGH[HUFLVHZKLOHO\LQJRQ\RXUEDFNSDVWWKHthPRQWKRI
pregnancy
X $YRLGDFWLYLWLHVZKLFKLQYROYHSK\VLFDOFRQWDFWRUGDQJHURI
IDOOLQJ
X .QRZ\RXUOLPLWV³SUHJQDQF\LVQRWDJRRGWLPHWRWUDLQIRU
athletic competition
X .QRZWKHUHDVRQVWRVWRSH[HUFLVHDQGFRQVXOWD 
TXDOLÀHGKHDOWKFDUHSURYLGHULPPHGLDWHO\LIWKH\RFFXU
REASONS TO STOP EXERCISE  
AND CONSULT YOUR  
HEALTH CARE PROVIDER
X([FHVVLYHVKRUWQHVVRIEUHDWK
X&KHVWSDLQ
X3DLQIXOXWHULQHFRQWUDFWLRQVPRUHWKDQ
SHUKRXU
X9DJLQDOEOHHGLQJ
X$Q\´JXVKµRIÁXLGIURPYDJLQD
VXJJHVWLQJSUHPDWXUHUXSWXUHRIWKH
PHPEUDQHV
X'L]]LQHVVRUIDLQWQHVV
Advice for Active Living During Pregnancy
Active Living:
! VHH\RXUGRFWRUEHIRUH
increasing your activity level 
during pregnancy
! H[HUFLVHUHJXODUO\EXWGRQ·W
RYHUH[HUW
! H[HUFLVHZLWKDSUHJQDQWIULHQG
RUMRLQDSUHQDWDOH[HUFLVH
program
! IROORZ),77SULQFLSOHVPRGLÀHG
IRUSUHJQDQWZRPHQ
! NQRZVDIHW\FRQVLGHUDWLRQVIRU
H[HUFLVHLQSUHJQDQF\
3UHJQDQF\LVDWLPHZKHQZRPHQFDQPDNHEHQHÀFLDOFKDQJHVLQWKHLUKHDOWKKDELWVWRSURWHFWDQGSURPRWHWKHKHDOWK\GHYHORSPHQW
RIWKHLUXQERUQEDELHV7KHVHFKDQJHVLQFOXGHDGRSWLQJLPSURYHGHDWLQJKDELWVDEVWLQHQFHIURPVPRNLQJDQGDOFRKROLQWDNHDQG
SDUWLFLSDWLQJLQUHJXODUPRGHUDWHSK\VLFDODFWLYLW\6LQFHDOORIWKHVHFKDQJHVFDQEHFDUULHGRYHULQWRWKHSRVWQDWDOSHULRGDQGEH\RQG
SUHJQDQF\LVDYHU\JRRGWLPHWRDGRSWKHDOWK\OLIHVW\OHKDELWVWKDWDUHSHUPDQHQWE\LQWHJUDWLQJSK\VLFDODFWLYLW\ZLWKHQMR\DEOHKHDOWK\
HDWLQJDQGDSRVLWLYHVHOIDQGERG\LPDJH
Healthy Eating:
! WKHQHHGIRUFDORULHVLVKLJKHUDERXWPRUHSHUGD\
WKDQEHIRUHSUHJQDQF\
! IROORZ&DQDGD·V)RRG*XLGHWR+HDOWK\(DWLQJDQGFKRRVH
KHDOWK\IRRGVIURPWKHIROORZLQJJURXSVZKROHJUDLQRU
HQULFKHGEUHDGRUFHUHDOIUXLWVDQGYHJHWDEOHVPLONDQG
PLONSURGXFWVPHDWÀVKSRXOWU\DQGDOWHUQDWLYHV
! GULQNJODVVHVRIÁXLGLQFOXGLQJZDWHUHDFKGD\
! VDOWLQWDNHVKRXOGQRWEHUHVWULFWHG
! OLPLWFDIIHLQHLQWDNHLHFRIIHHWHDFKRFRODWHDQG 
FRODGULQNV
! dieting to lose weight is not recommended during 
pregnancy
Positive Self and 
Body Image:
! remember that it is normal 
to gain weight during 
pregnancy
! accept that your body 
shape will change during 
pregnancy
! HQMR\\RXUSUHJQDQF\DV
DXQLTXHDQGPHDQLQJIXO
H[SHULHQFH
For more detailed information and advice about pre- and postnatal exercise, you may wish to obtain a copy of a booklet entitled Active Living During 
Pregnancy: Physical Activity Guidelines for Mother and Baby  © 1999.    Available from the Canadian Society for Exercise Physiology,   
www.csep.ca.  Cost: $11.95
Public Health Agency of Canada. The sensible guide to a healthy pregnancy. Minister of Health, 2012.  Ottawa, Ontario K1A 0K9. http://www.phac-aspc.
gc.ca/hp-gs/guide/assets/pdf/hpguide-eng.pdf. HC Pub.: 5830 Cat.: HP5-33/2012E. 1 800 O-Canada (1-800-622-6232) TTY: 1-800-926-9105.
Davenport MH. Charlesworth S. Vanderspank D. Sopper MM.  Mottola MF. Development and validation of exercise target heart rate zones for over-
weight and obese pregnant women. Appl Physiol Nutr Metab. 2008; 33(5): 984-9.
Davies GAL. Wolfe LA. Mottola MF. MacKinnon C. Joint SOGC / CSEP Clinical Practice Guidelines: Exercise in Pregnancy and the Postpartum  
Period. Can J Appl Physiol. 2003; 28(3): 329-341.
Mottola MF, Davenport MH, Brun CR, Inglis SD, Charlesworth S, Sopper MM. VO 2 peak prediction and exercise prescription for pregnant women.  
Med Sci Sports Exerc. 2006 Aug;38(8):1389-95.PMID: 16888450
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Appendix A4 Letter of Information and Consent to Participate as a Control 
 
May 14, 2012 
 
South Street Hospital • University Hospital • Victoria Hospital and Chi ldren’s Hospital 
 
Letter of Information 
 
Investigation Title: Bringing an evidence-based Nutrition and Exercise Lifestyle 
Intervention Program (NELIP) for obese pregnant women into 
clinical practice. 
 
Study Investigators:   
 
1. Dr. Debbie Penava, MD, FRCSC, Department of Obstetrics & Gynecology;  
2. Dr. Michelle Mottola, PhD, Exercise and Pregnancy Lab, UWO;  
3. Dr. Barbra deVrijer, MD, FRCSC, Department of Obstetrics & Gynecology 
 
The purpose of this letter of information is to provide you with the information you need to make 
an informed decision about participating in this study. 
 
Introduction 
 
You are being invited to participate in a research study looking at the effects of a nutrition and 
exercise lifestyle intervention program (NELIP) in the prevention of excessive pregnancy weight 
gain, and a reduction in the incidence of diabetes and cardiovascular disease risks, for mothers 
and their offspring, through an early initiation of healthy living. 
 
Purpose of the Study 
 
The main goal of the study is to prevent childhood obesity early through a lifestyle intervention 
aimed at at-risk pregnant women to prevent excessive weight gain during pregnancy and 
gestational diabetes.  There will be a total of 30 program patients and 30 controls enrolled in this 
study. 
 
Inclusion/Exclusion Criteria 
 
In order to participate in this study, you must be a patient who has been referred to the 
specialized “My Clinic” at the London Health Sciences Centre.  You must also be: 
• At least 18 years old 
• 12-16 weeks pregnant 
 
In order to participate in this study, you must not: 
• Have a medical reason that would keep you from walking regularly. 
• Have existing type 2 diabetes. 
 
If you are unsure about whether you are eligible to participate in this study, please discuss with 
your “My Clinic” physician. 
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Study Procedures 
 
Oral Glucose Tolerance Test 
 
If you are interested in participating in this study, we ask that you inform us before you have 
your oral glucose tolerance test performed in the clinic.  The oral glucose tolerance test 
performed as part of standard care is slightly different than the one used for the study: 
• The standard oral glucose tolerance test for patients at “My Clinic”: To prepare for this 
test you must eat no food or drink anything except water for 12 hours (overnight) before 
your visit. Once in the lab, we will draw 10mL of blood once you have been sitting 
quietly for 20 minutes. Two more blood samples will be withdrawn after we have given 
you a sweet liquid containing 75 g of glucose to drink. These samples will be taken at 60 
and 120 minutes after you have taken the drink, while you are resting comfortably in a 
chair. The total blood withdrawn from your vein is approximately 20 mL (less than 2 
tablespoons).  The blood samples will be used to analyze the changes in your blood sugar 
over time in response to the glucose drink that we gave you. 
• The study oral glucose tolerance test for patients in this research study: You prepare for 
the test the same way.  An extra 5mL (for a total of 15mL extra) will be withdrawn at the 
same time points as above.  The total blood withdrawn from your vein is approximately 
35 mL (less than 3 tablespoons).  The additional blood samples will be used to analyze 
the changes in your lipids (fat) and blood insulin (a hormone that responds to blood 
sugar) over time in response to the glucose drink that we gave you.  This is not part of 
standard care. 
 
Because participants in the study need a different test than non-participants, we will need to 
know if you are interested in participating before you complete your oral glucose tolerance test.  
Rarely, the results of your oral glucose tolerance test may show that you have a medical 
condition which means you cannot participate in the study.  If this is the case, your physician 
will inform you. 
 
Questionnaires/Diaries 
 
At your first visit at My Clinic, you will be asked to fill out a Weight and Health History 
Questionnaire and the PARmed-X for Pregnancy.  Completing these items is part of standard 
care; your doctor will ask you to complete them whether you enroll in the study or not.  
However, we will be using information from these questionnaires in the study. 
 
If you agree to participate in this study, you will also be asked to complete a Physical Activity 
Survey at your initial visit.  This is not part of standard care. Once you have completed the 
glucose tolerance test, you will be asked to complete a food diary for 3 consecutive days, 
including one weekend day.  You will also be given a pedometer and a log sheet to record the 
number of daily steps you take.   
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Group Assignment 
 
Once you have completed these logs, you will be assigned at random, that is, by a method of 
chance (like the flip of a coin), to one of the study groups.  There are three study groups you may 
be assigned to: 
1. The first group (10 participants) will be assigned to receive the full Nutrition & Exercise 
Lifestyle Intervention Program (NELIP) intervention.  If you are assigned to this group, 
you will be introduced to a walking program at London Health Sciences Centre – 
Victoria Hospital, and will be encouraged to come to the hospital 3 to 4 times per week 
for walks ranging from 25-40 minutes throughout your pregnancy.  You will be given a 
pedometer and log sheet in order to record your daily steps.  You will also receive 
information on the dietary program you will be following throughout your pregnancy. 
2. The second group (10 participants) will be assigned to receive only the exercise 
component of the NELIP intervention.  If you are assigned to this group, you will be 
introduced to the walking program and encouraged to come to LHSC for your walks, but 
you will not receive any dietary intervention. 
3. The third group (10 participants) will be assigned to receive only the nutrition 
component of the NELIP intervention.  You will not be involved in the walking 
program, but you will receive information on the dietary program you will be following 
throughout your pregnancy. 
 
Alternatively, if you are not willing to be randomized to one of the three study groups, you can 
choose to be in the control group.  These 30 control participants will be assigned to receive 
standard care; that is, they will not receive any of the NELIP intervention.  However, we will still 
need your consent to be a control participant, as we will still be taking additional blood samples, 
having you complete additional questionnaires, and having you return to the clinic at 6 and 12 
months post-partum. 
 
Nutrition Program 
 
If you are assigned to group 1 or group 3, you will receive the nutrition component of the 
NELIP.  After completing the 3-day food diary, you will receive instructions on our nutrition 
program. The purpose of the controlled nutrition regime is to promote good eating habits, to 
control excessive weight gain and to regulate your blood sugar levels. Once per week throughout 
the program, you will be required to record for a 24-hour period everything you ate and drank 
during that time period. This will assist us in adjusting your nutrition program as your pregnancy 
progresses.  
 
Controlled Walking Program 
 
If you are assigned to group 1 or group 2, you will receive the exercise component of the NELIP, 
which consists of a walking program in which you will walk for 25 minutes, 3 to 4 times per 
week, adding 2 minutes each week, until 40 minutes is reached and then maintained until 
delivery.  You will be given a pedometer and log sheet to keep track of daily steps.  You should 
follow a walking pace that is easy for you to maintain without you becoming breathless.  You 
will have the option of either walking an indoor track at My Clinic with supervision by a study 
volunteer, on a treadmill in your own gym, on an outdoor trail (weather permitting) or in your  
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neighbourhood.  We encourage you to come to the clinic for your walks. 
 
Visits 
 
If you agree to participate in this study as a program participant (groups 1-3), we will ask you to 
come to My Clinic every Friday to track weekly weight gain. 
 
 At 28 Weeks of pregnancy 
 
As part of your standard care, your doctor will request a second oral glucose tolerance test.  As at 
your initial test, if you choose to participate in this study, an additional 20mL of blood will be 
drawn to assess changes in your lipids and blood insulin levels. 
 
At 34 Weeks of pregnancy 
 
As part of your standard care, your doctor will request a third oral glucose tolerance test.  As at 
your initial test, if you choose to participate in this study, an additional 20mL of blood will be 
drawn to assess changes in your lipids and blood insulin levels. 
 
You will also be asked to complete the Physical Activity Survey again.  You are under no 
obligation to complete this questionnaire, and you may refuse to answer any or all of the 
questions. 
 
Delivery 
 
After you deliver, one of our research staff will visit you and your new baby within 6 to 18 
hours.  We will collect your baby’s length and birth weight and the weight of your placenta from 
your hospital chart.  We will measure head size, chest size and abdomen size of your baby, using 
a cloth tape measure. We will record placental weight.  We will record any complications which 
may have occurred during delivery, and the APGAR scores. These are numbers that refer to your 
baby’s colour, breathing and reflexes at 1 minute and 5 minutes after birth.  Finally, we will 
measure 6 skin fold sites on your baby. The sites that we will measure are: the front and back of 
the arm, between the shoulder blades, the front of one thigh, the front of the belly by the belly-
button, and just above the hip bone. There are no known risks with this procedure. 
 
Six Months Postpartum 
 
At 6 months post delivery, we will ask you to return to the clinic for a follow-up visit.  We will 
ask you to complete the Breastfeeding and Infant Feeding Questionnaire and the Physical 
Activity Survey. You are under no obligation to complete these questionnaires, and you may 
refuse to answer any or all of the questions. 
 
As previously described, we will measure your infant’s length, weight and head circumference, 
chest circumference, abdomen circumference, hip circumference, arm circumference, mid-thigh 
circumference and calf circumference. We will also measure 6 skinfold sites on your infant. The 
front and back of the arm, between the shoulder blades, the front of the thigh, the front of the 
belly by the belly-button and just above the hip bone. Infant circumferences will be taken using a  
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soft cloth tape measure, and a special infant skinfold caliper will be used for the skinfold 
measurements. There are no known risks with this procedure. You will be weighed and we will  
 
also measure your waist (at the area of your belly-button) and hips (at the widest part of your 
hips) using a soft cloth tape.  
 
The total time for this visit will be one hour. 
 
Twelve Months Postpartum 
 
At 12 months post delivery, we will ask you to return to the clinic for a follow-up visit.  We will 
ask you to complete the Breastfeeding and Infant Feeding Questionnaire and the Physical 
Activity Survey. You are under no obligation to complete these questionnaires, and you may 
refuse to answer any or all of the questions. 
 
As previously described, we will measure your infant’s length, weight and head circumference, 
chest circumference, abdomen circumference, hip circumference, arm circumference, mid-thigh 
circumference and calf circumference. We will also measure 6 skinfold sites on your infant. The 
front and back of the arm, between the shoulder blades, the front of the thigh, the front of the 
belly by the belly-button and just above the hip bone. Infant circumferences will be taken using a 
soft cloth tape measure, and a special infant skinfold caliper will be used for the skinfold 
measurements. There are no known risks with this procedure. You will be weighed and we will 
also measure your waist (at the area of your belly-button) and hips (at the widest part of your 
hips) using a soft cloth tape.  
 
The total time for this visit will be one hour. 
 
Risks and Benefits to You if You Participate in This Study 
 
There are no known risks to your participation in this study.  If you are randomized to 
one of the groups receiving the exercise component and you have previously been 
inactive, you may experience muscle cramps and fatigue when you begin the exercise 
program.  
 
Participation in this study may be of no direct benefit to you.  The benefits to you and your 
family may include prevention of excessive weight gain during pregnancy and minimizing 
weight retention after the baby is born. You may also gain information about healthy eating and 
how to be active for you and your family that will last you a lifetime.  
 
Other Information You Need to Know About Taking Part in This Study 
 
Participation in this study is voluntary. You may refuse to participate, refuse to answer any 
questions, or withdraw from the study at any time with no effect on your future care. If you 
withdraw from the study at any time, we may still use your data compiled up to that point.    
 
If your medical condition changes throughout the course of the study, and your physician  
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determines that continuation in the study would impair your health or that of your baby, you will 
be advised at that time to discontinue the program. We will still include you in the study and you 
will continue to receive ongoing medical care. If, during the course of this study, new 
information becomes available that may relate to your willingness to continue to participate, this 
information will be provided to you by the investigators. 
 
An alternative to the procedures described above is not to participate in the study and 
continue on just as you do now. There is no guarantee of a personal benefit by participating 
in the study. Regardless of your decision to participate you would still receive continuing 
medical care.   
 
Biological Specimens 
 
Any specimen(s) (e.g., blood) obtained for the purposes of this study will become the property of 
the researchers/sponsors and once you have provided the specimens you will not have access to 
them. 
 
The specimen(s) will be discarded or destroyed once they have been used for the purposes 
described in the protocol. 
 
Compensation and Costs 
 
Your participation in this research will not involve any additional costs to you or your health 
care insurer, and you will not be compensated for your participation in the study. We will 
arrange for you to park free of charge at Victoria Hospital for those visits that are required 
only for this research study.  For study visits that occur with your clinical care, your 
parking will not be covered.  
 
Specific Things You Should Know About Confidentiality 
 
Your confidentiality will be respected. The information collected will be used for this current 
research project only. Your records will be kept locked in a cabinet in a secure office. You will 
be given a unique identification number and will not be personally identified in any way.  
However, it is important to note that the original signed research consent form and the data 
which will follow will be included in your health record.  If the results of this study are published 
or presented to groups of other researchers or health care professionals, they will be presented as 
group data, and your name will not be associated with any specific result without your consent to 
the disclosure.   
 
We will strive to ensure the confidentiality of your research–related records. Absolute 
confidentiality, however, cannot be guaranteed, as we may have to disclose certain 
information under certain laws. Representatives of the University of Western Ontario Health 
Sciences Research Ethics Board may require access to your study-related records or may 
need to follow-up with you to monitor the conduct of this research.      
 
While we will do our best to protect your information there is no guarantee that we will be able 
to do so.  The inclusion of your initials and your date of birth may allow someone to link the data  
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and identify you. 
 
Contact Information 
 
If you have any questions about your rights as a research participant or the conduct of 
the study you may contact Dr. David Hill, Scientific Director, Lawson Health Research 
Institute, (519) 667-6649. 
  
What You Need to Know About Signing the Consent Form 
 
If during the course of this study new information becomes available that may relate to your 
willingness to continue to participate, this information will be provided to you by the study 
investigators. 
 
You do not waive any legal rights by signing the consent form. You will be given a copy of 
this letter of information and consent form once it is signed.  
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Bringing an evidence-based Nutrition and Exercise Lifestyle Intervention Program 
(NELIP) for obese pregnant women into clinical practice  
 
Consent to Participate as a Control 
 
I have read the letter of information, have had the nature of the study explained to me and I agree 
for myself and my child to participate as controls. All questions have been answered to my 
satisfaction. 
 
While I do not wish to participate in this research study, I am willing to have my information 
used as a control participant.  This involves: 
 
• Having additional blood samples (15-20mL total) taken at oral glucose tolerance tests at 
intake, 28 weeks, and 34 weeks; 
• Completing additional questionnaires not required for clinical care; and  
• Returning to the clinic at 6 and 12 months post-partum for study follow-up. 
 
 
___________________________________  
Control Participant Name (print) 
 
___________________________________ _______________________ 
Control Participant Signature     Date 
 
 
Person conducting the informed consent process including administration and explanation of the 
form:  
 
 
___________________________________  ________________________________ 
Printed name       Date 
       
__________________________ 
Signature 
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 Bringing an evidence-based Nutrition and Exercise Lifestyle Intervention Program 
(NELIP) for obese pregnant women into clinical practice  
 
Consent to Participate 
 
I have read the letter of information, have had the nature of the study explained to me and I agree 
for myself and my child to participate. All questions have been answered to my satisfaction. 
 
 
 
___________________________________  
Participant Name (print) 
 
___________________________________ _______________________ 
Participant Signature     Date 
 
 
Person conducting the informed consent process including administration and explanation of the 
form:  
 
 
___________________________________  ________________________________ 
Printed name       Date 
       
__________________________ 
Signature 
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Appendix A7 Seven-Day Pedometer Log 
 
 
 
 
 
 
 
 
PEDOMETER/ACCELEROMETER LOG 
 
NELIP STUDY – UNIVERSITY OF WESTERN ONTARIO 
 
Unique ID # Pedometer # Accelerometer # 
DAY 1 DAY 2 DAY 3 
PUT ON PEDOMETER AS SOON AS YOU GET OUT OF BED & SET IT TO ZERO 
Did you exercise?  Y     N 
IF YES:  Steps Before: 
_______________ 
               Steps After:    
_______________     
Did you exercise?  Y     N 
IF YES:  Steps Before: 
_______________ 
               Steps After:    
_______________     
Did you exercise?  Y     N 
IF YES:  Steps Before: 
_______________ 
               Steps After:    
_______________     
ONCE IN BED, RECORD  
Total Steps: 
ONCE IN BED, RECORD  
Total Steps: 
ONCE IN BED, RECORD  
Total Steps: 
 
DAY 4 DAY 5 DAY 6 Day 7 
PUT ON PEDOMETER AS SOON AS YOU GET OUT OF BED & SET IT TO ZERO 
Did you exercise?  Y     
N 
IF YES:   
Steps Before: 
_____________ 
Steps After:   
_____________ 
Did you exercise?  Y     
N 
IF YES:   
Steps Before: 
_____________ 
Steps After:   
_____________ 
Did you exercise?  Y     
N 
IF YES:   
Steps Before: 
_____________ 
Steps After:   
_____________ 
Did you exercise?  Y     
N 
IF YES:   
Steps Before: 
_____________ 
Steps After:   
_____________ 
ONCE IN BED, 
RECORD  
Total Steps: 
ONCE IN BED, 
RECORD  
Total Steps: 
ONCE IN BED, 
RECORD  
Total Steps: 
ONCE IN BED, 
RECORD  
Total Steps: 
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NELIP Suggested Meal Plan 
Water żżżżżżżż 
 
TIME FOOD GROUP CHOICES ONE DAY SAMPLE MENU ALTERNATIVES 
B
R
EA
K
FA
ST
  
 
Target = ~25 grams of carbohydrates 
Starch Foods 1 ½ cup cereal (e.g. Shreddies) or ½ small multigrain bagel  or 1 slice whole wheat bread 
 
Protein Foods 1 1 egg or 1 ounce (~30 grams) low-fat cheese   or  1 Tbsp (15 mL) peanut butter 
 
Milk 2 1 cup (250 mL) skim milk or  ¼ cup (60 g) low-fat fruit yogurt  
Extra 
Vegetables  recommended 
2 slices tomato or ½ cup mushrooms & green pepper (in 
omelette) 
 
A
M
 
 S
N
A
C
K
 
Target = ~25 grams of carbohydrates 
Starch Foods 1 ½ whole wheat English muffin or 1 small oat bran muffin or  5 multigrain crackers 
 
 
Fats & Oils 1 1 tsp (5 mL) soft (e.g. Becel) margarine  
Vegetable & 
Fruit 1 
1 cup vegetable juice or ½ medium apple or 1 small orange  
or 2 apricots 
 
 
LU
N
C
H
 
Target = ~35 grams of carbohydrates 
Starch Foods 2 2 slices whole wheat or pumpernickel bread or 1 cup legumes  
Protein Foods 3 3 ounces lean meat or skinless poultry  e.g. 90 g or 1 medium roasted chicken breast  
Fats & Oils 2 1 tsp olive oil and ¼ avocado or 2 tsp regular salad dressing  
Milk 1 ½ cup (125 mL) skim milk or ½ cup (125 mL) plain fortified soy beverage  
Extra 
Vegetables recommended 
1 slice tomato and 1 cup spinach salad (with avocado and oil 
above) or 2-3 slices cucumber and a celery stick or  
½ cup sliced sweet peppers 
 
PM
 
SN
A
C
K
 
Target = ~25 grams of carbohydrates 
Starch Foods 1 5 whole wheat crackers or 4 melba toasts or 1 slice flax bread or ½ small multigrain bagel  or 1/3 cup legumes  
Vegetable & 
Fruit 1 
½ cup mixed raw vegetables or ½ cup grapes or 1 kiwi  
or 4 tsp raisins (small box) or ½ small banana  
Fats & Oils 1 10 peanuts or 5 cashews or 1 Tbsp (15 mL) cream cheese  
D
IN
N
ER
 
Target = ~45 grams of carbohydrates 
Starch Foods 2 ҀFXSULFHor baked beans or 1 cup pasta or 1 cup (250 mL) potato or corn or couscous   
Fats & Oils 2 2 tsp (10 mL) oil or soft, non-hydrogenated margarine or 2 Tbsp (30 mL) low-fat sour cream  
Vegetable & 
Fruit 1 ½ cup (125 mL) cooked carrots or peas or mixed vegetables  
Protein Foods 3 3 ounces lean meat or poultry or fish; or ½ cup legumes e.g. 90 g roast beef or a medium pork chop  
Milk 1 ½ cup (125 mL) skim milk or plain fortified soy beverage  
Extra 
Vegetables  recommended 
½ cup (125 mL) tossed salad or ½ cup (125 mL) broccoli or  
½ cup (125 mL) cauliflower or ½ cup (125 mL) green beans  
EV
EN
IN
G
 
SN
A
C
K
 
Target = ~25 grams of carbohydrates 
Starch Foods 1 ½ whole wheat pita or 3 cups (750 mL) plain popcorn  
Fats & Oils 1 1 Tbsp (15 mL) low-fat mayo or 1 tsp (5 mL) margarine  
Protein Foods 1 ¼ cup (60 mL) canned salmon or tuna or low-fat cottage cheese or 1 egg or 1 Tbsp (15 mL) peanut butter  
Vegetable & 
Fruit 1 
8 baby carrots or 1 cup celery or 1 peach or 1 kiwi or 1 small 
orange or ½ pear or ½ cup berries 
 
 
B
ED
 
SN
A
C
K
 Target = ~25 grams of carbohydrates 
Starch Foods 1 1 fig Newton cookie or ¾ cup plain cheerios or ½ cup oat flakes or 2 rice cakes 
May substitute with 1 
cup of low-fat plain 
chocolate, strawberry, 
or vanilla ice cream. Milk 2 
¾ cup (175 g) low-fat plain yogurt or 1 cup (250 mL) skim milk or 
1 cup (250 mL) plain fortified soy beverage 
FBBT 2009 
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